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CHAPTER 1
Iron Chaperones for Mitochondrial Fe-S Cluster Biosynthesis and Ferritin
Iron Storage
1.1

Prelude
Even though only a small amount of iron is required on a daily basis, life

without iron is impossible. Iron is present as a cofactor in many enzymes that
play a vital role in keeping our body healthy. Various proteins help maintain ironhomeostasis by assisting in metal storage, transfer, influx and efflux. Among
these proteins, metallo-chaperones bind metal and deliver it to cognate enzymes.
While much has been reported about Copper and Nickel chaperones, much less
is known about iron-chaperones. The recent identification of cytosolic iron
chaperone -Poly (rC) Binding Protein (PCBP1), which transfers iron to the
storage protein, ferritin, has sparked interest in the field. The PCBP protein family
is hypothesized to serve as iron chaperones in a tissue specific manner.
Frataxin, an iron chaperone within the mitochondria, has been shown to
participate within the iron sulfur cluster biosynthetic pathway. Therefore, to
understand disorders and diseases related to iron transport, investigating iron
chaperones at the molecular level is extremely important. My project involved the
characterization of the Poly (rC) Binding Protein-2 (PCBP2) and Drosophila
frataxin at a structural level to determine the molecular details of how these
proteins bind and deliver iron.
The first chapter of my thesis describes the current understanding of these
Fe-chaperones. This work is being published as a review article and I contributed
as a coauthor by writing the first section of the paper and producing the first
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figure. This chapter will serve as the background for my thesis. The reference for
the article is: Poorna Subramanian, Andria V. Rodrigues, Sudipa Ghimire-Rijal
and Timothy L. Stemmler, “Iron Chaperones for Mitochondrial Fe-S Cluster
Biosynthesis and Ferritin Iron Storage,” Current Opinion in Chemical Biology,
2011, In press.

1.2

Introduction
Iron is essential for life and its unique chemical characteristics are often

exploited in nature to assist cells in performing inherently complex oxidation
chemistry, promote oxygen transport/storage and drive electron transfer
pathways (1). Iron is typically absorbed into the body through diet (2) and on
average, humans absorb 1 to 2 mg of iron each day (3). Although the amount of
iron abstracted from the diet is low, tight regulation of absorbed iron is critical, as
humans have no physiologic pathway to excrete iron. Once consumed, over 60%
of the iron is incorporated into hemoglobin through developing erythroid
precursors and finally into mature red blood cells. Other destinations for Fe
include storage inside ferritin or distribution throughout the body for incorporation
into cofactor sites of iron metalloproteins. As a cofactor, Fe is often found
associated within iron-sulfur (Fe-S) clusters, found as mononuclear Fe-S, 2Fe2S, 4Fe-4S and higher stoichiometric clusters common to nature (4). Given the
body’s need to absorb and maintain appropriate iron levels, Fe reuse and
recycling from degraded sources is another method the body uses to maintain
iron homeostasis. A simple breakdown in any of these pathways can lead to
conditions that are detrimental to human health.
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When maintained at balanced levels, iron is essential for cellular and
organism viability but it leads to a variety of physiological and developmental
irregularities when deficient or in excess. (3). Disorders related to a breakdown in
iron homeostasis are among the most common human diseases. Diseases of
iron overload are highly prevalent, with the hepatological disorder hereditary
hemochromatosis being one of the most common (5). Hemochromatosis patients
absorb two to three times more iron than normal dietary iron levels. Excess iron
is often deposited in the liver and redox chemistry performed by unregulated
metal can kill the cell/organism. Neuronal iron accumulation is a phenotype of
numerous neurodegenerative disorders (Parkinson’s disease, Alzheimer’s
disease, Friedreich’s ataxia, others). In these disorders, unregulated but redox
active metal is pooled within specific regions of the brain, generating oxidative
stress through iron catalyzed formation of reactive oxygen species (ROS) (6).
ROS can damage membrane phospholipids and generate reactive aldehydes
that damage proteins, leading to accumulation of misfolded protein aggregates.
While examples of the toxic effects of iron overload are numerous, iron deficiency
is an even larger human health issue affecting billions (7). Iron deficiency leads
to decreased cognitive development in children (8) and continued long-term
deficiency leads to numerous other health related issues (3). It is clear that
biological pathways controlling iron reactivity are essential; however it is also
clear that the pathways ensuring proper iron delivery are equally important for
maintaining cell viability.
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Many pathways that regulate cellular iron homeostasis are controlled at
the genetic and at the protein level (9-10). As outlined in the transferrin cycle,
iron is imported through endocytosis of Fe3+ loaded transferrin (Tf) interacting
with the transferrin receptor (Tf-R), in a tightly regulated feedback loop controlled
at the genetic and protein level (Figure 1.1). In eukaryotes, iron can be diverted
to the mitochondria where it is utilized during heme production or during Fe-S
cluster assembly (pathway #1 in Figure 1.1). During mitochondrial Fe-S cluster
assembly, the ISC machinery proteins work together to form clusters that can be
loaded onto apo-mitochondrial proteins or pumped out of the mitochondria in
some manner (labeled X) to be used by the cytosolic Fe-S cluster assembly
machinery (CIA). Cytosolic iron can also be directed for storage into ferritin in an
inert form for future use (pathway #2 in Figure 1.1). While there are obviously
other fates for cellular iron, recently two iron chaperones have been discovered
that control iron delivery in the pathways highlighted above. An overview of the
structure and biophysical properties leading to iron binding by these two
chaperones is the basis of this review.

1.3

Fe-S cluster biosynthesis iron chaperones
In eukaryotes, the mitochondrial ISC assembly is the major pathway for

Fe-S cluster production. Key players in the yeast ISC machinery include the
assembly scaffold protein (either Isu1 or 2, for clarity we will refer to only Isu1),
the cysteine desulfurase (Nfs1) that provides sulfur to Isu1, the accessory protein
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Figure 1.1. Major pathways for iron incorporation/utilization within a cell. Two pathways for
Fe2+ utilization highlighted within the review include: 1) Frataxin and its role in
mitochondrial Fe-S cluster assembly via. the ISC-Machinery (* including the cysteine
desulfurase/Isd11 complex that provides sulfur); 2) PCBP and its role in ferritin associated
iron storage.

(Isd11) that works in complex with Nfs1, a ferredoxin (Yah1) working with a
ferredoxin reductase (Arh1) to provide electrons for the reaction, and the putative
iron chaperone protein frataxin (Yfh1) (11). Protein orthologs are highly
conserved and found in all eukaryotes, while in prokaryotes most are found
within the ISC pathway while variants of these proteins exist within the sulfur
mobilization (SUF) and the nitrogen fixation (NIF) assembly pathways (12). Isu1
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is one of the most conserved proteins (13-14), containing three conserved
cysteines critical for de novo Fe-S cluster assembly (15-16). Sulfur transfer
between Nfs1 and Isu1 occurs as a persulfide (-SSH) through a direct interaction
between partners (17); insight into the nature of this interaction has come from a
recent structural characterization of bacterial orthologs (18). In vivo, Yfh1 is
essential for Fe-S cluster maturation (19), and an interaction between Yfh1 and
Isu1/Nfs1/Isd11 is critical for cluster biosynthesis (20). In vitro, frataxin was
shown to deliver iron to the scaffold protein to stimulate Fe-S cluster assembly
(21). Based on these and additional reports (see review (11)), frataxin was
shown to play a direct role in mitochondrial Fe-S cluster assembly, possibly by
serving as the iron chaperone(20, 22), deficiency of which has direct
consequences regarding cellular oxidative stress (23).
Insight into frataxin’s function has come from investigating the structure
and iron binding abilities of numerous orthologs (24). Frataxin is a member of the
αβ sandwich motif family, with N- and C-terminal helices constructing one
molecular plane and the second constructed by at least five anti-parallel βstrands (25-30). Key structural features for the frataxin orthologs include highly
conserved, surface exposed acidic residues lining the helix-1/strand-1 junction, a
short predominately unstructured N-terminal region in eukaryotic orthologs only,
and a C-terminal region in the human and bacterial proteins that confers stability
(31). The iron binding ability of frataxin was first identified in the yeast ortholog
associated with iron-induced aggregation stabilized by low salt/high oxygen
solution conditions (32). Monomeric bacterial, yeast, fly and human frataxin have
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since been shown to bind iron with micromolar affinity (21, 28, 33-36), and in vivo
mutations preventing Yfh1 aggregation show no Fe-S cluster phenotypes under
normal growth conditions (37), indicating while protein aggregation may be
important under oxidative stress, monomeric frataxin is active during Fe-S cluster
assembly. Experimental data verify conserved acidic residues on frataxin’s helix1/strand-1 junction are directly involved in iron binding (28, 33, 35). Structural
studies confirm that monomeric frataxin binds high spin Fe2+ in a symmetric 6coordinate ligand environment containing only oxygen and nitrogen ligands, in
agreement with the conserved acidic residues identified by NMR as iron ligands
(35-36, 38). These data suggest as a starting point for iron delivery, frataxin
binds iron using carboxylate side chain oxygens from conserved Asp and Glu
residues from the helix-1/strand-1 iron binding sites, most likely with assistance
from water molecules. Binding in this manner would predispose iron for delivery
to Isu1 (Figure 1.2) since the exposed metal would be positioned for delivery to
the protein partner and the charged surface surrounding the metal would be
amenable for forming an interaction with a complementary charged region of the
protein partner.
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Figure 1.2. Molecular details of the 2 Fe2+ binding sites on Yfh1 (PDB #2GA5), and the Cys
rich active site on Isu1 (modeled structure) coupled with possible Isu1 Fe2+ binding sites
on the protein’s C-terminus. Ferrous iron (blue dots) shown with arrow denoting Fe
transfer events between the two proteins.
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Yfh1 undergoes an iron-stimulated interaction with Isu1/Nfs1 (20, 39-40) in
agreement with frataxin interacting directly with members of the ISC assembly
machinery. In vivo mutational studies place frataxin’s acidic helix-1/strand-1
ridge, with residues on the Yfh1 β-sheet surface, as interacting with Isu1 (39-43).
In vitro binding interactions show frataxin/scaffold binding is iron dependent and
occurs at nM binding affinity (36, 44-45). Chemical shift mapping studies provide
spectroscopic confirmation that Isu1 interacts with Yfh1 on frataxin’s acidic helix1/strand-1 ridge utilizing the protein’s β-sheet surface, in close agreement with in
vivo mutational analysis (45). In eukaryotic systems, activity assays for Fe-S
cluster production confirm iron loaded frataxin stimulates in vitro Fe-S cluster
assembly, possibly by delivering the Fe2+ required for cluster production (21, 36,
46). Direct structural details of the frataxin/scaffold interaction are however
lacking. Two recent structural papers shed light on the potential binding
interaction between these protein partners. Crystallographic data on the Aquifex
aeolicus IscU ortholog, with cluster bound, confirm the three conserved Cys
residues implicated in assembly form the active site of IscU (47). An even more
exciting result comes from the structure of the bacterial cysteine desulfurase
(IscS) in complex with IscU (18). This structure shows IscU binds to IscS such
that the IscU Cys active site is in close contact with the IscS Cys residue
implicated in forming the persulfide used for sulfur transfer. Binding of Isu1 to
Nfs1 in this manner would prevent frataxin from interacting in this region,
assuming sulfur delivery happens before iron delivery. Irrespective of this
assumption, mounting evidence suggests all proteins in the ISC machinery form

10
a complex that promotes the formation of a stable macromolecular complex used
to accomplish cluster assembly, so the frataxin piece of this puzzle would need to
fit in a unique location on Isu1. A likely candidate for where Yfh1 could bind to
Isu1 is on the scaffold protein’s C-terminal helix (Figure 1.2) (45). The charge
distribution from the electrostatic potential surface of Isu1 in this region matches
nicely to the Yfh1 β-sheet surface. Conserved acidic/basic residues on Isu1’s Cterminal helix could serve as the initial Fe2+ binding residues, metal could then
translocate to the scaffold’s active site (45). Positional orientation of bacterial
frataxin on the IscS/U from small angle X-ray scattering studies (48) suggest that
such an orientation may be possible, although this orientation is likely to be
altered between the prokaryotic and eukaryotic orthologs since the accessory
protein Isd11 found only in eukaryotes is likely also positioned in this region.
Following Fe delivery to Isu1 by Yfh1, the binding energetics are reduced,
frataxin dissociates from its partner and Isu1 is primed for delivery of the second
Fe atom required to make a 2Fe-2S cluster.
Recently it has been suggested frataxin may participate in Fe-S cluster
biosynthesis by regulating activity of the cysteine desulfurase. NMR mapping
studies of bacterial frataxin (CyaY) onto the bacterial IscS suggest residues lining
frataxin’s β-sheet ridge tangential to the C-terminus of helix 1, with helix-1
residues, participate in IscS binding (49). Mutagenesis and binding studies
implicate a region on one IscS monomer, in proximity to the persulfide site in the
second molecule in the dimer, as the CyaY binding surface on IscS (18). Recent
studies suggest CyaY acts as an iron-dependent inhibitor of cluster formation by
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negatively regulating IscS activity (49). In contrast, another recent report
suggests human frataxin acts as an allosteric activator of Nfs1 (50). Regardless,
binding of frataxin to the ISC machinery is important during assembly and it will
be interesting to see how this binding is finally correlated to iron delivery and
assembly.

1.4

Ferritin iron chaperones
Cellular pathways directing iron storage are essential for preventing iron

toxicity during overload and ensuring availability during deficiency. Storage is
directed by the 4-helix bundle protein ferritin (51). Mammalian cytoplasmic
ferritins exist as a 24 subunit multimer of 2 ferritin subunits: H chain (21,000
kDa), which controls the ferroxidase chemistry coupled to iron storage, and the L
chain (19,000 kDa). Apo-ferritin H and L chains self-assemble to form a spherical
protein shell that stores up to 4500 iron atoms as feroxyhydrite within the central
cavity. Iron storage involves two key steps: iron oxidation, leading to formation of
a μ-oxo(hydroxo)-bridged di-Fe(III) intermediate, and mineralization, depositing
the intermediate as inert ferrihydrite mineral. Ferrous iron is first delivered to a
hydrophilic channel at three-fold symmetry sites on ferritin. H-chain surface
exposed residues H118 (52) and C130 (53), with threefold channel funnel-like
forming residues Asp131 and Glu134 (54), are used during iron import. Binding
of an iron chaperone must therefore proceed through direct contact with ferritin’s
three-fold iron entry site (see Figure 1.3).
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Figure 1.3. Structural details of PCBP’s as a ferritin iron chaperone. Top Right: PCBP2
total projected structure based on domains 1,2 (PDB #2JZX) and domain 3 (PDB #2P2R)
structure linked together for visual clarity associated with 3 bound iron atoms (blue dots).
Top Left: structure of the human ferritin 24-mer (PDB #3AJO) with iron loaded (blue dot)
trimeric symmetry center. Bottom Left: expansion of the ferritin trimeric interface with
residues from three subunits involved in Fe2+ loading (H118 and C130). In addition,
residues (D131, E134) on the inner side of the iron incorporation gate that support metal
exchange are also given.
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Recently, the human poly (rC)-binding protein (PCBP) was shown to
function as a cytosolic iron chaperone that delivers Fe2+ to ferritin (55). The RNAbinding PCBP protein family was originally shown to be important in mRNA
stabilization and translational activation/silencing (56). PCBPs have 3 KH
(hnRNP K homology) domains, with structures of the two N-terminal domains
and the third domain of PCBP2 being characterized (57-58). Expression of
human PCBP1 recovered an iron loading deficiency for human ferritin expressed
in yeast (55). PCBP1 binds to ferritin in vivo and in vitro facilitates iron loading.
PCBP1 binds 3 iron atoms at µM binding affinity comparable to frataxin’s iron
affinity (24). Metal binding sites on PCBP are unknown; however recent iron
structural data indicate PCBP1/2 bind ferrous iron in a 6-coordinate
oxygen/nitrogen ligand environment (author’s unpublished results). Although
molecular details of PCBP as an iron chaperone are still emerging, it is
interesting to note that thermodynamic and structural data regarding PCBP iron
binding are so similar to that of the Fe-S assembly iron chaperone.

1.5

Conclusions
Evidence that frataxin and PCBP are iron chaperones is compelling,

although clarification of their function at the genetic, molecular and atomic levels
will be important for understanding how they operate. There are still many
questions that remain regarding the identity of other chaperones, how iron is
loaded onto a chaperone and what promotes chaperone metal specificity?
Possible candidates for the first question are the glutaredoxins Grx3 and 4, which
are members of the thioredoxin (Trx) fold family. Grx3/4 are central for cellular
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iron trafficking and a strong dependence of iron binding for Grx3/4 on core
components in the ISC pathway indicate Grx3/4 bind iron as a Fe-S cluster (59).
The ability to form a bridging 2Fe-2S cluster with Fra1/2 for activation of Aft1
(60), coupled with the direct dependence of Grx3/4 on iron loading into heme,
Fe-S clusters, and ribonucleotide reductase, suggest iron activated by Grx3/4
may be utilized by other dedicated assembly factors (59). Frataxin and PCBP are
most likely the forerunners of more iron chaperones that await discovery.
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CHAPTER 2
Molecular Characteristics of the Drosophila Frataxin-Isu Interaction during
Fe-S Cluster Assembly

2.1

Prelude
Conserved during evolution from prokaryotes to eukaryotes, Frataxin is a

nuclear encoded protein targeted to mitochondria that contributes to the
maintenance of cellular iron homeostasis. Frataxin is directly involved in the
production of Fe-S clusters, which are essential cofactors for proteins in various
pathways within the cell. Frataxin is reported to interact directly with other
proteins partners in the Iron Sulfur Cluster (ISC) assembly pathway. In order to
better understand how these proteins interact, we undertook a study of frataxin
with binding partners using proteins in the Drosophilla system. My contribution
related to this study was to study the interaction between two ISC-scaffold
proteins (frataxin and Isu) in the absence of iron with the use of Isothermal
Titration Calorimetry (ITC). In addition, I compared the sequence alignment of
Frataxin orthologs from different species: bacteria, yeast, drosophila and human.
The structural correlations I performed were done using ClustalW to show the
protein conservation during evolution.
In detail, chapter 2 of this thesis studies molecular characterization of Dfh
and DIsu during Fe-S cluster assembly pathway. This work is under preparation
for publication. The manuscript in its near final format is listed under the following
reference: Swati Rawat, Sudipa Ghimire-Rijal, Yogapriya Murugesan, Gregory
Holmes-Hampton,

Paul

Lindahl

and

Timothy

L.

Stemmler,

“Molecular
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Characteristics of the Drosophila Frataxin-Isu Interaction during Fe-S Cluster
Assembly,” 2011, In preparation.

2.2

Introduction
Frataxin, a nuclear encoded protein targeted to the mitochondria, is

essential for cellular iron homeostasis as part of the mitochondrial iron-sulfur (FeS) cluster biosynthesis assembly pathway (19, 61-63). Frataxin deficiency in
humans leads to the neurodegenerative disorder Friedreich’s Ataxia (FRDA),
which affects 1 in 50,000 (61, 64). The disorder is characterized by mitochondrial
iron overload, a breakdown in the Fe-S cluster assembly pathway and a general
disruption in iron regulation (62, 65). Although numerous roles have been
attributed to frataxin, a direct function during mitochondrial Fe-S cluster assembly
seems the most likely (21, 36). Recent data suggest frataxin directly participates
in Fe-cofactor assembly by possibly serving either as a mitochondrial iron
chaperone, supplying the iron required for cluster assembly, or as a regulator for
the enzymatic activity of assembly protein partners (49, 66).
In eukaryotes, the major pathway for production of Fe-S clusters is
localized within the mitochondria and controlled by the eukaryotic ISC assembly
pathway. The ISC machinery in eukaryotes/prokaryotes is constructed of a
scaffold assembly protein (Isu/IscU, respectively), a cysteine desulfurase
(Nfs/IscS), an accessory protein (Isd11) found in eukaryotes only, and the protein
frataxin (20, 67-69). Frataxin has been shown to interact directly with Isu, Nfs and
Isd11 individually and within a multiprotein complex in vivo (20, 40, 43, 70). In
vitro, frataxin has been shown to both stimulate Isu1 activity and to positively and
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negatively regulate Nfs1 activity by interacting directly with the protein partner
(49, 66). Frataxin is an iron binding protein and the binding interaction between
frataxin and Isu is metal dependent (28, 35, 70-71), suggesting metal sharing is a
key component in assembly activity, however the interaction between the
bacterial frataxin (CyaY) and cysteine desulfurase (IscS) is metal independent
(49, 72), suggesting regulation of the cysteine desulfurase by frataxin is an
elastic event. Modelling studies, based on experimental data suggesting frataxin
binds to the scaffold/desulfurase complex at the IscS dimer interface cleft with
IscU attached (18, 70), was recently confirmed by reconstructions of the X-ray
scattering data (72). Combined, these data indicate a direct influence of frataxin
on Fe-S cluster assembly by interaction with the multi-protein ISC machinery.
Investigation of frataxin’s interaction with each protein in the machinery is
essential for understanding the molecular contacts that drive frataxin’s
participation within the pathway. Genetic and structural studies of frataxin alone
show the protein is highly conserved in evolution and has an α-β sandwich
architecture (Figure 2.1). Frataxin binds iron at micromolar affinity utilizing key
conserved acidic residue side chains on the protein’s helix-1/strand-1 ridge (3536, 71). Iron is bound anaerobically as high spin ferrous metal in a symmetric 6coordinate ligand environment constructed of only oxygen and nitrogen based
ligands (36, 70). Iron loaded frataxin binds to Isu with nanomolar affinity utilizing
conserved residues on the protein’s β-sheet plane, with support from helix-1
residues (70). When sulfur is supplied chemically to the frataxin/Isu/Fe system, a
high percentage of bound iron is converted into a functional 2Fe-2S cluster that
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has been confirmed structurally and spectroscopically (36, 70). These data
strongly support a direct interaction of frataxin to Isu in a manner highly
consistent with frataxin serving as an iron chaperone for the pathway.

Figure 2.1. Top: ClustalW alignment for Drosophila, Human, Yeast and Bacterial frataxin
orthologs. Bottom three sequences represent structurally characterized frataxin orthologs.
Secondary structural elements (α-helix in blue and β-sheets in yellow) are given below the
sequences. Bottom: Ribbon diagrams for Drosophila, Human, Yeast and Bacterial
frataxins. Structural figures were made using crystal structure of Human (PDB ID# 1EKG)
while solution structures of Yeast (PDB ID# 2GA5) and Bacterial (PDB ID# 1SOY) frataxins
using PYMOL software. The structure of Drosophila frataxin was simulated using SwissProt server with human frataxin as template.
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In this report, we utilized proteins in the fly model system to further
elucidate the molecular details of how frataxin interacts with the scaffold protein.
Our recent characterization studies of Drosophila frataxin (Dfh) show the protein
is highly stable against degradation/aggregation seen with the human and yeast
model systems, and the stability of the fly orthologs is shared with the other
proteins in the ISC machinery. Isothermal titration calorimetry (ITC) was used to
characterize the binding affinity and stoichiometry between DIsu and iron, and
DIsu and Dfh in the presence and absence of metal. Frataxin’s ability to stimulate
2Fe-2S cluster assembly on the scaffold protein was tested using a previously
established activity assay. X-ray absorption spectroscopy was used to
characterize the metal spin state and the electronic properties, and the structure
of iron bound to DIsu alone and in the DIsu ± Fe-Dfh complex in the presence
and absence of chemical sulfide. Metal speciation and additional characterization
of the iron electronic environments of metal bound to Dfh were characterized by
Mössbauer spectroscopy. Finally, the influence of cluster assembly on the DIsu
fold was tested using fluorescence spectroscopy. Combined these data provide
structural and mechanistic insight into the frataxin-scaffold interaction that assists
in driving the mitochondrial Fe-S cofactor production pathway.

2.3

Materials and Methods

2.3.1 Cloning, Expression, and Protein Purification
The plasmid for expression of mature Dfh (minus 59 amino terminal
residues) and protein purification has been described previously (36). DIsu cDNA
was obtained, prepared from the adult head tissue in a pOT2 vector, from the
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“Drosohila Genomics Resource Center” (Clone ID: GH01635). DIsu cDNA was
PCR amplified and sub-cloned into the directional pET151/D-TOPO expression
vector. The sequence represents DIsu residues 25-154 of the complete open
reading frame after excluding the predicted mitochondrial targeting sequence but
including an N-terminal methionine. Positive clones were verified by DNA
sequencing. Recombinant plasmid was transformed into BL21 (DE3) “codon
plus” E. coli competent cells for protein expression. Expression was optimized by
varying induction temperatures and IPTG concentrations. Expression and the
stepwise purification of the 130 amino acid DIsu protein closely followed our
protocol outlined for the yeast ortholog (36, 70). Briefly, the plasmid was
transformed into BL21(DE3) CodonPlus cells and grown by auto induction (73) at
25°C for ca. 24 hrs before harvesting by centrifugation. Protein isolation steps
were all performed at 4° C. Cells were resuspended in 50 mM NaPO4 (pH 7.5),
300 mM NaCl, 20 mM Imidazole and 5 mM β-Me in the presence of Complete
EDTA free Protease inhibitor cocktail (Roche). Cells were then lysed by two
passes through a French Press cell at high pressure (1100 psi), followed by 2
rounds of sonication (50% power for 20 seconds) and finally centrifuged at high
speed (21000 rpm) for 1 hour. Crude soluble fraction was filtered (0.20 µm) and
loaded onto a HisPrep FF Ni column (Pharmacia) using an Imidazole gradient in
the range of 20 – 500 mM (DIsu protein elutes at ~ 150 mM). DIsu containing
fractions were pooled and concentrated to ca. 1mL by centrifugation using 10
kDa cutoff centricons (Millipore) spun at 5000 rpm. The concentrated retentive
solution was run over a Sephadex 75 size exclusion column (Pharmacia)
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equilibrated with 20 mM HEPES buffer (pH 7.5), 150 mM NaCl and 5 mM β-Me.
Following this protocol, we were able to attain high purity DIsu based on gel
analysis. Mass spectrometric analysis of DIsu indicated a molecular weight of
18508.4 Da (theoretical molecular weight is 18511.2 Da). Like Dfh, DIsu was
very stable against degradation. Protein could be concentrated up to 27 mg/L
and stored anaerobically at -20° C and -80° C, retaining complete activity as
judged by our Fe-S cluster activity assay, for multiple weeks.

2.3.2 Isothermal Titration Calorimetry (ITC) Binding Studies
The binding affinity and stoichiometry were characterized for the interaction
between ferrous iron ± Dfh and DIsu using ITC. DIsu, Dfh and ferrous ammonium
sulfate solutions were prepared anaerobically in 20 mM HEPES (pH 7.5) with
150 mM NaCl. All experiments were conducted anaerobically at 30°C. The Fe
into DIsu ITC experiments were

conducted

using

a

VP-ITC

titration

microcalorimeter (MicroCal, Inc.) by titrating a 2.1 mM ferrous iron solution into a
1.4 mL volume of a 90 µM DIsu solution; Dfh into DIsu experiments were
performed by titrating a 0.9 mM solution of either apo- or holo-Dfh into a 70 µM
solution of apo-DIsu. Following an initial 2 µL titrant solution injection, 29
additional injections of 10 µL each were titrated into the DIsu solution. The period
between injections was 10 min, and the syringe stirring speed was held constant
at 500 rpm. All experiments were conducted in duplicate on independent protein
and iron samples to ensure data reproducibility. Data analysis was performed
utilizing the Origin 5.0 Scientific Graphing and Analysis Software (provided by
MicroCal) by applying a nonlinear least-squares curve-fitting algorithm to
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determine the stoichiometric ratio and dissociation constant during the reaction.

2.3.3 Fe-S Cluster Assembly Activity Assay
The in vitro DIsu Fe-S cluster assembly activity was measured for
chemically and DFh assisted delivery of ferrous iron using a previously
established activity assay. All protein and substrate samples were made
anaerobic on an Schlenk line and stored under positive argon pressure. ApoDfh
was incubated with ferrous ammonium sulfate at a metal:protein ratio of 1:1 for
20 min at 30° C. Cluster assembly was initiated by addition of ferrous iron
directly, or as part of the HoloDfh complex, to a 500 µL solution containing 100
µM DIsu, 4.3 mM DTT, and 2.4 mM sodium sulfide. The final Fe concentration
was 100 µM and all samples were buffered in 20 mM HEPES and 150 mM NaCl
(pH 7.5). Controls with DIsu or Dfh alone and with DIsu or Dfh, DTT, and sodium
sulfide were prepared under the solution conditions listed above. Fe-S cluster
assembly was monitored by UV-visible absorption spectroscopy. Absorption
spectra between 200 and 600 nm were recorded. A time course for the reaction
progress was prepared by spectral detection every 30 s using the spectral
wavelength of 426 nm (a chromophore characteristic for [2Fe-2S] clusters).
Assembly data were collected in independent reproducible samples to obtain
data statistics.

2.3.4 X-ray Absorption Spectroscopy (XAS)
XAS was used to study the electronic properties and ligand coordination
geometry of iron at different stages during Fe-S cluster assembly. All samples
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were prepared anaerobically within a glove box (PlasLabs) using protein and iron
solutions initially degassed on a Schlenk line and stored under an Ar(g)
atmosphere. XAS samples were prepared in 20 mM HEPES buffer (pH 7.5), 150
mM NaCl, 5 mM β-Me and 30% glycerol. Independent duplicate samples were
prepared for the following systems: A) Fe-DIsu was prepared by incubating DIsu
with 0.95 equivalent of ferrous iron, B) Fe-Dfh prepared by incubating 0.95
equivalents of ferrous iron for 10 minutes, C) Fe-Dfh+DIsu was prepared by first
incubating Dfh with 0.95 equivalent of ferrous iron for 10 minutes at room
temperature, then adding 1 equivalent of DIsu and D) Fe-Dfh+DIsu+S was
prepared by first incubating Dfh with 0.95 equivalent of iron for 10 minutes at
room temperature, then adding stoichiometric equivalents of DIsu and Na2S. All
samples were allowed to incubate for an additional 60 minutes in an Ar(g)
atmosphere to ensure cluster and complex formation. Samples were loaded into
Lucite sample cells wrapped with Kapton tape, flash frozen in liquid nitrogen,
removed from the glove box and stored in liquid nitrogen until data collection was
performed.
XAS data were collected at the Stanford Synchrotron Radiation Laboratory
(SSRL) on beamline 7-3, which is equipped with a single rhodium-coated silicon
mirror and a Si [220] double crystal monochromator. Harmonic rejection was
achieved by detuning the monochromator 50%. Samples were maintained at 10
K using Oxford Instrument continuous-flow liquid helium cryostat. Protein
fluorescence excitation spectra were collected using a 30-element Ge solid-state
array detector. XAS spectra were measured using 5 eV steps in the pre-edge
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regions (6900 - 7094), 0.25 eV steps in the edge regions (7095-7135 eV) and
0.05 Å-1 increments in the extended X-ray absorption fine structure (EXAFS)
region (to k = 13.5 Å-1), integrating from 1 to 20 seconds in a k3 weighted manner
for a total scan length of approximately 40 minutes. X-ray energies were
calibrated by collecting an iron foil absorption spectrum simultaneously with
protein data. Each fluorescence channel of each scan was examined for spectral
anomalies prior to averaging and spectra were closely monitored for
photoreduction. Protein data represents the average of 5 to 6 scans.
XAS data were processed using the Macintosh OS X version of the
EXAMSPAK program suite (74), integrated with Feff version 7.2 for theoretical
model generation. Data reduction and processing followed previously established
protocols. Analysis of the X-ray absorption near edge structure (XANES) 1s→3d
transitions were completed using the EDGE_FIT EXAFSPAK subroutine. EXAFS
fitting analysis was performed on raw/unfiltered data following a previously
established strategy (35). EXAFS data were fit using both single- and multiplescattering theoretical model amplitude and phase functions for an Fe-O/N, Fe-S,
Fe•••Fe and a Fe-imidazole unit interactions. During spectral simulations, metalligand coordination numbers were fixed at half-integer values and only the
absorber-scatterer bond length (R) and Debye-Waller factor (

2

) were allowed to

freely vary (75).

2.3.5 Mössbauer Spectroscopy
Mössbauer spectroscopy was used to characterize the speciation and
electronic properties of iron bound to Dfh. A sample of Fe57 loaded Dfh, 1.8 mM
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in concentration, was prepared anaerobically in 20 mM HEPES buffer (pH 7.5)
and 150 mM NaCl by first dissolving iron metal in a 1:1 mixture of HCl and HNO3,
diluting the metal with water to a final iron concentration of 80 mM ([HCl] - 120
mM, [HNO3] - 150 mM). An aliquot of the 80 mM Fe stock solution was removed
and reacted with a 1:1 molar ratio of sodium dithionite and added to the protein
sample for a final iron concentration of 1.7 mM. The Fe-Dfh sample was then
incubated anaerobically for 30 minutes and frozen in Mössbauer sample cups
cooled using an aluminium block pre-cooled with liquid nitrogen. All samples
were stored under liquid nitrogen until the spectra were collected.
Mössbauer spectra were collected using a MS4 WRC model spectrometer
(SEE Co., Edina, MN) equipped with a CCR4K closed cycle helium compressor
(Sumitomo Cryogenetics). Spectra were analyzed using the WMOSS software
package (SEE Co., Edina, MN). All values for the isomer shift and quadropole
splitting were reported relative to the alpha Fe foil at a temperature of 298 K.

2.3.6 Fluorescence Spectroscopy
Changes in structural characteristics of DIsu in the presence of substrates
were monitored using fluorescence spectroscopy. The fluorescent dye 1,8Anilinonaphthalenesulfonate (ANS), which selectively binds to solvent exposed
hydrophobic regions in molten globular proteins (70, 76) was used to probe
structure changes on DIsu in the presence and absence of Fe alone, S alone and
Fe + S combined. ANS studies were performed using a 3 mL fluorescence
cuvette (Starna), equipped with septa, containing a 50 µM DIsu solution in 20
mM HEPES buffer (pH 7.5), 150 mM NaCl. All buffers, samples and the cuvette
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were initially degassed using an Ar(g) purged Schlenk line. DIsu samples were
prepared in the presence and absence of ferrous iron and sulfide independently
and then as a mixture. Single time point fluorescence measurements were made
for the protein samples first incubated for 10 minutes, followed by incubation for
10 minutes with 10 µM ANS (λexcite = 371 nm, λemission = 490 nm). Spectra were
collected at room temperature on a QuantaMaster fluorimeter (PTI) at 1 nm
intervals with 0.25 second integration times and 5 mm slit widths. Spectra were
collected on independent reproducible sample sets.

2.4

Results

2.4.1 Isothermal Titration Calorimetry (ITC) Binding Studies
ITC was used to measure the metal to protein stoichiometry and energetics
for association of iron binding to DIsu. Ferrous iron was titrated into apo-DIsu
anaerobically under buffer conditions that stabilize the protein (20 mM HEPES,
pH=7.5, 150 mM NaCl). Changes in heat associated with iron binding by DIsu
are shown in the raw ITC data in Figure 2A (top), with the data following an
exothermic iron-binding event. The heat released vs. the molar ratio plot follows
bipasic behaviour common to systems with two binding events (Figure 2.2A
(bottom)). The best fit simulation to the molar ratio plot was obtained using a two
iron binding site model, with ca. 2 iron atoms binding at 475 ± 166 nM and 64.5 ±
17 nM affinities (Table 2.1).
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Figure 2.2. Raw isothermal titration calorimetry data (top) and binding isotherm data
(bottom) of: A) Fe(II) titration into DIsu, B) Fe-Dfh titrated into DIsu and C) Dfh titrated into
DIsu. A grey line in each bottom panel shows the simulated fit to the binding isotherm
data. Data were collected anaerobically at 30 C in 20 mM HEPES (pH 7.5) and 150 mM NaCl.

Table 2.1. Average ITC simulation results. Averaged values for stoichiometry (N1 and N2)
and dissociation constants (KD1 and KD2) are provided with error bars.

Sample

N1

KD1

N2

KD2

Fe - DIsu

1.21 ± 0.25

475 ± 166 nM

1.40 ± 0.07

64.5 ± 17 nM

Fe-Dfh + DIsu

1.72 ± 0.30

530 ± 43.5 nM

0.41 ± 0.22

673 ± 22 nM

Dfh + DIsu

---

---

---

---

ITC was also used to test the metal dependence as well as binding affinity
and stoichiometry of Dfh binding to DIsu. Experiments were performed under
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conditions that stabilize HoloDFh as a protein monomer. In the presence of
metal, Dfh binds to DIsu in an exothermic manner (Figure 2.2B (top)). The best-fit
simulation of the molar ratio data suggests ca. 2 equivalents of monomeric
HoloDFh binds to ApoDIsu with an affinity in the nanomolar range (KD1 = 530 ±
43.5 nM and KD2 = 673 ± 22 nM) (Table 2.1). However, no appreciable heat is
absorbed or released then titrating ApoDfh into ApoDIsu (Figure 2.2C - top).

2.4.2 X-ray Absorption Spectroscopy (XAS)
XAS was used to characterize the electronic and structural properties of
iron bound to DIsu at various stages durin Fe-S cofactor production. Samples
were prepared for: DIsu + iron, Fe-Dfh + DIsu, and Fe-Dfh + DIsu + sulfide.
XANES spectra, with an expansion of the pre-edge 1s→3d transition features,
were offset for clarity and given for each sample in Figure 2.3 and Figure 2.3
(inset), respectively. Pre-edge transition analysis (including pre-edge peak
energies and absorption area) were determined for all samples based on
simulation analysis, and simulation parameters were most consistent with Fe(II)
bound to DIsu, Dfh and Dfh/DIsu alone existing in a high spin, fairly octahedral
six

coordinate

ligand

coordination

geometry

(Table

2.2).

In

the

Fe-

Dfh/DIsu/sulfide sample, edge energies and high pre-edge area are most
consistent with a portion of the metal existing in a four coordinate tetrahedral
ligand coordination geometry consistent with a 2Fe-2S cluster.
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Figure 2.3. XANES spectra of Fe bound in the following sample: A) Fe-DIsu, B) Fe-Dfh +
DIsu and C) Fe-Dfh + S2- + DIsu. Individual spectra were equally offset for clarity. Inset:
Expansion of the individual 1s →3d transition peaks in the same order as listed in the full
figure.

Simulations of the EXAFS portion of each XAS spectrum was used to
characterize the metal-ligand metrical parameters for iron bound in each sample
(Figure 2.4 A,C,E and G). The single pronounced feature in the Fourier transform
of the Fe-DIsu EXAFS indicates metal is bound in a fairly symmetric ligand
environment centered at ca. 2 Å (Figure 2.4B). EXAFS simulations show ferrous
iron bound to DIsu is stable in a symmetric metal-ligand nearest neighbour
coordination environment constructed only by oxygen and nitrogen based ligands
(Table 2.3) at average bond lengths of 1.99 Å (coordination number (CN) of 3.0
±1.0) and 2.15 Å (CN of 2.0 ± 1.0), respectively. A similar environment is
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observed in the Fourier transform of Fe-Dfh (Figure 2.4D). Simulations of the FeDfh EXAFS shows nearest neighbour coordination geometry again constructed
of only oxygen and nitrogen based ligands, at average bond lengths of 1.99 and
2.15 respectively.

Table 2.2. Analysis of pre-edge and edge features from Fe-XANES spectra displayed in
Figure 2.3. Pre-edge transition energies and areas determined using EDG_FIT software.

Sample
Fe-DIsu

Pre-edge peak
energy (eV)
7112.41 ± 0.12

Total pre-edge
area
3.91 ± 0.5

Edge inflection
energy (eV)
7122.45 ± 0.1

4.01 ± 2.0

7122.48 ± 0.3

8.01 ± 5.0

7122.66 ± 0.5

7113.78 ± 0.14
Fe-Dfh + DIsu

7112.49 ± 0.24
7113.81 ± 0.13

Fe-Dfh + DIsu + S

7111.99 ± 0.03
7112.79 ± 0.05
7113.95 ± 0.15
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Figure 2.4. EXAFS and Fourier transforms of iron bound to the proteins at various stages
during the Fe-S cofactor production. Raw EXAFS data is shown in black with simulated fit
in green for: A) Fe-DIsu, C) Fe-Dfh + DIsu and E) Fe-Dfh + S2- + DIsu. Corresponding fourier
transform plots of raw EXAFS data in black for: B) Fe-DIsu, D) Fe-Dfh + DIsu and F) Fe-Dfh
+ S2- + DIsu.
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Table 2.3. Summary of best fit EXAFS simulation results for iron at various stages during
cofactor formation. Values reported are the average of at least two independent
measurements.

Sample
Fe - DIsu

Fe-Dfh + DIsu

Fe-Dfh + S +
DIsu

Fe-Nearest Neighbor
Ligandsa
R(Å) C.N.
2e
Atomb
c
d

Fe•••Long Range
Ligandsa
Ato R(Å) C.N.
2e
c
d
mb
C
3.13 1.5 3.01

O/N

1.99

3.0

3.78

O/N

2.15

2.0

2.94

O/N

1.99

2.0

3.93

C

3.1

2.0

4.32

O/N

2.15

1.5

4.27

C

3.51

1.5

3.81

O/N

2.06

1.0

1.07

Fe

2.73

0.5

1.40

S

2.28

1.0

1.57

F’ f
0.32

0.41

0.69

a

Independent metal-ligand scattering environment
Scattering atoms: O (Oxygen), N (Nitrogen), C (Carbon), S (Sulfur) and Fe (Iron)
c
Metal-ligand bond length
d
Metal-ligand coordination number
e
Debye-Waller factor given in Å2 x 103
f
Number of degrees of freedom weighted mean square deviation between data and fit
b

When Fe-Dfh is added to DIsu, the average metal ligand nearest neighbour
coordination geometry is very similar to that observed in the Fe-DIsu sample,
with only slight variations in the Debye-Waller values (a measure of the metalligand bond order), suggesting a dramatic decrease in bond symmetry.
Reduction in bond symmetry for Fe-Dfh + DIsu is further indicated by the
unrealistically low CN values obtained for the two independent ligand systems.
These ligand systems that have bond lengths (and pre-edge features) consistent

33
with a 6-coordinate Fe-O/N ligand system, however the low coordination number
values suggest a destructive overlap between unique but irresolvable multiple
independent metal-ligand systems. In all three cases, long range carbon
scattering is observed at ca. 3.1 Å. In the case of the Fe-Dfh/DIsu sample, an
additional ligand environment at 3.51 Å was also observed and the long range
scattering for this sample was much more pronounced that the other two. The
long rang scattering in all samples could not however be fit with any appreciable
Fe•••Fe scattering.
Addition of sulfide to the Fe-Dfh/DIsu system causes a dramatic distortion in
the metal-ligand coordination environment compared to the other samples.
Fourier transforms of the EXAFS data indicate a nearest-neighbor environment
distinct from the other three samples with a well pronounced long range
interaction at ca. 2.7 Å (Figure 2.4H). Simulations in the nearest neighbor EXAFS
contribution indicate both Fe-ON and Fe-S scattering at averaged values of 2.06
Å and 2.28 Å, respectively. The low coordination numbers for each environment
reflect again a highly disordered iron-ligand environment or possibly multiple
unique environments with EXAFS that destructively interfere. In this sample only,
long range Fe•••Fe scattering is observed at 2.7 Å. This data could not be fitted
to long-range carbon scattering in the range of R > 3.0 Å.

2.4.3 Mössbauer Spectroscopy
Mössbauer spectroscopy was used to characterize the speciation and
electronic environment of the iron bound to Dfh. Mössbauer spectroscopy can
give very precise information about chemical, structural and magnetic properties
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of bound metal. Figure 2.5 shows Mössbauer spectra of iron bound to Dfh at 5 K
(A) and 100 K (B). The spectrum at 100 K looks like typical high-spin Fe (II) metal
coordinated by weak field ligands, such as O/N atoms (Figure 2.5).

Figure 2.5. Drosophila Frataxin Homolog (Dfh) Mössbauer spectra collected with 0.7G field
applied parallel to the sample. A) Spectrum at 5K and B) Spectrum at 100K. Red line is a
simulation of the data using δ = 1.33 mm/sec, ΔEq= 3.51mm/sec, Γ = 0.367 mm/sec.

Simulations of these data show quadrupole splitting (ΔEq) = 3.51 mm/s and
an isomer shift (d) = 1.33 mm/s; results were confirmed by running a ferrous
control (Table 2.4). The 5K spectrum shows broadening of the high-energy line
(magnetic hyperfine). This data further confirms our previous result that iron
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bound to Dfh is high spin using only O/N based ligands. In a previous report, the
mössbauer parameters for yeast frataxin (Yfh1) deficient mitochondria showed
the presence of typical high-spin ferric iron bound to oxygen/nitrogen in an
octahedral arrangement. No ferrous iron was observed in that case (refer
Matzanke 2002 paper).

Table 2.4. Analysis of parameters for Mössbauer simulations of iron bound to Dfh.

Sample

δ (mm/sec)

ΔEQ (mm/sec)

Γ (mm/sec)

Fe (aq)

1.35

3.06

0.591

Dfh

1.33

3.51

0.367

δ – Isomer shift
ΔEQ – Electric quadrupole
Lw – line width at full width half maximum of signal
2.4.4 Fluorescence Spectroscopy
Fluorescence spectroscopy was used to measure the extent of the molten
globular state and fold of DIsu under Fe-S cluster assembly conditions. ANS
binding is often used to characterize the globular nature of biomolecules, since
this fluorescent probe selectively binds to solvent exposed hydrophobic regions
in molten globule proteins. ANS binding induces a fluorescence signal in the
vicinity of 500 nm (λexcite = 371nm), whereas well-folded proteins bind little dye
and exhibit little fluorescence. A large fluorescence signal centred at 468 nm is
observed upon Apo-DIsu exposure to ANS (Figure 2.6, combination of dashed &
dotted line), suggesting the presence of exposed hydrophobic residues in a
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molten globule form of the DIsu. At these concentrations, ANS by itself in buffer
had negligible fluorescence (control not shown). Addition of Fe (II) or sulfide to
DIsu caused only a minimal change in the ANS fluorescence (Figure 2.6, dashed
and doted lines, respectively), suggesting that binding of each substrate
individually does not distort the overall fold of the protein. Incubation of both
ferrous iron and sulfide to DIsu prior to addition of ANS results in a substantial
decrease of ANS signal intensity (Figure 2.6, solid line), suggesting a dramatic
decrease in solvent accessibility to hydrophobic residues in the protein following
or concurrent with the production of the Fe-S cluster.

Figure 2.6. Fold and structural rearrangement of DIsu during cluster formation using ANS
fluorescent probe. Fluorescence of ANS bound to DIsu alone (combination of dashed &
dotted line), DIsu incubated with Fe(II) (dashed line), DIsu incubated with S2- (dotted line)
and DIsu incubated with Fe(II) and S2- together (solid line).
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2.5

Discussion
Biosynthesis of iron sulfur clusters has been an intriguing subject because

of the complexity involved in the pathway. Current research on the ISC assembly
pathway suggests a multiprotein complex between frataxin, assembly scaffold
and cysteine desulfurase/Isd11 exits in eukaryotes. Therefore it involves several
protein-protein interactions between these proteins. The interaction between
bacterial cysteine desulfurase (IscS) and the scaffold (IscU) has been recently
characterized and the Barondeau group has analyzed the entire complex in
eukaryotes (human). Their studies suggest the formation of a ~180 kDa hetero
octomer (α2β2γ2δ2) containing two chains each of frataxin, ISU, NFU, and ISD11.
Based on recent studies it occurs that there are significant differences in the
assembly process in eukaryotes and prokaryotes. Particularly, the role of frataxin
is still controversial, as it has been shown to inhibit the cysteine desulfurase
activity in prokaryotes but to activate the cysteine desulfurase activity in
eukaryotes. We believe that significant differences between prokaryotic and
eukaryotic systems suggest that interaction between protein orthologs may be
partially unique for the model system under investigation. In this report we
characterize the molecular and structural details of the interaction between the
frataxin and the scaffold using D.melanogaster proteins. Characterization of
these interactions in the fly system may help explain the key differences in the
frataxin function among different species (iron chaperone or storage v/s pathway
regulator). This study provides details about one of the steps involved in this
pathway. Our ultimate goal is to study each of these protein-protein interactions
in detail starting with frataxin-scaffold interaction. This will allow us to provide a
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detailed multiprotein complex involved in the assembly process. In this report we
have characterized the electronic and structural changes in the bound iron at
various stages during cluster assembly on D.melanogaster Isu (DIsu). We also
report here that interaction between D.melanogaster frataxin (Dfh) and DIsu is
metal dependant. We have also looked into detail on structural changes in DIsu
upon cluster binding. In short this report summarizes the biochemical and
structural details of frataxin-scaffold interaction enlightening the molecular details
of this pathway.
Frataxin has been studied in several orthologs like human, yeast and
bacteria. However there have been several issues regarding the stability of the
protein in these orthologs. Yeast frataxin is very prone to oxidative damage and
subsequent aggregation while human frataxin is susceptible to N-terminal
autodegradation. Thus, our finding of Dfh as a stable eukaryotic ortholog was
very important as Dfh is highly stable with melting temperature of ~59.2°C. This
high stability and resistance to aggregation of Dfh has greatly facilitated our
characterization of the DIsu-Dfh interaction in the current paper. Like Dfh, DIsu is
also very well behaved protein as compared to other Isu orthologs. Usually wild
type Isu is very insoluble and unstable in other eukaryotic orthologs, thus an
aspartate mutant (D37A) is usually used for invitro studies in yeast. In case of
DIsu, the wild type protein is soluble even under low salt conditions and is stable
and active for more than two weeks. It is for these reasons, that we have
performed a comprehensive invitro characterization of Dfh-DIsu interaction and
the iron delivery to the DIsu protein.
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ITC was used to find the iron and partner protein binding ability of DIsu.
The iron binding affinity and optimal metal: protein stoichiometry of DIsu were
characterized to elucidate the biophysical details of iron binding by DIsu. Under
our current solution conditions, DIsu binds 2 Fe atoms with nanomolar binding
affinity (KD1= 475 ± 166 nM and KD2 = 64.5 ± 17 nM) (Table 2.1). Similar binding
affinities have been observed in other orthologs as well. This iron binding affinity
is higher than Dfh’s iron binding affinity (average KD = 6 µM) suggesting that the
transfer of iron to DIsu is thermodynamically favourable. In addition to this, we
also observed the interaction between the Dfh and DIsu using ITC. As shown
previously we observed that holo Dfh interacts with apo DIsu with nanomolar
binding affinity (KD1 = 530 ± 43.5 nM and KD2 = 673 ± 22 nM) (Table 2.1).
However, these proteins are not observed to interact in absence of iron. Thus our
results suggest that it would be energetically favourable for Dfh to interact with
DIsu in presence of iron. This protein-protein binding will then allow metal
transfer to the scaffold and after removal of metal from Dfh would cause Dfh
release from DIsu. Previously, we have characterized the interaction of Dfh with
yeast Isu and observed the same result (binding affinity of ca. 0.21 µM). It is
important to note that holo Dfh was able to interact with the yeast Isu. These
results closely match the binding affinity of approximately 0.15 µM obtained
between the human proteins, and in both cases, binding is energetically
favourable. The fact that the Dfh binding affinity and stoichiometry with respect to
DIsu so closely match those seen for complementary proteins in the human
system only further emphasize the idea that the functional role of frataxin toward
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Fe-S cluster biosynthesis is conserved between organisms. However, the
presence of Nfs1/Isd11 will change the binding affinities between these proteins
and future studies in this direction are ongoing in our lab.
We performed structural characterization of bound iron at different stages
during assembly of Fe-S cluster on the DIsu scaffold protein, as this provides
insight into how metal is used during cofactor assembly. Our goal was to know
the ligand environment and geometry of bound iron at different stages including
the intermediates involved in the process. Based on Fe K-edge XANES data for
these samples, we observed that Fe is present in high spin ferrous form, which is
the biological available form of iron. In absence of sulfide, the iron has all O/N
based ligand environment in DIsu bound Fe and Fe - Dfh - DIsu bound sample.
However, the metrical details of the iron bound in these samples differ
suggesting a difference in ligand environment upon delivery to DIsu. We don’t
observe any sulfur ligation for iron bound to the DIsu sample, suggesting a
different iron binding site other than the active cysteines involved in cluster
binding. While this technique cannot directly distinguish between oxygen- and
nitrogen-based ligands, the technique can yield bond length with a very high
degree of accuracy (0.02 Å). These accurate values can then be used to provide
insight into probable coordination ligand types and geometries. Significant
change takes place in the XAS data upon addition of Sulfur to the system. It
suggests the formation of multinuclear iron species consisting of 2Fe-2S cluster
formations. The EXAFS data of this sample suggests Fe ligation at 2.73 Å and S
ligation at 2.28 Å, emphasizing the formation of Fe-S cluster and these values
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are consistent with a 2Fe-2S cluster formation. The electronic environment of Febound Dfh was further characterized by using Mössbauer spectroscopy, which
again suggests the presence of high spin iron in an all O/N based ligand
environment. This further supports our already published XAS results on Fe
bound Dfh sample.
Our results indicate that binding of Fe-S cluster on the DIsu scaffold
induces a structural change in the protein making it more folded. Isu scaffold
proteins in general exist in a dynamic equilibrium between folded and unfolded
state in order for them to function as a scaffold. This gives them flexibility to
modulate their fold based on interacting protein or substrate to successfully carry
a particular reaction. Previously, ANS fluorescence has been used to
characterize the molten globule nature of T. maritime IscU and yeast Isu in
solution. Similar results are observed for DIsu suggesting it also has a molten
globule structure. However, no significant change in the fluorescence of the
protein is observed upon either Fe or S binding only. We also don’t observe any
red shift in the data as seen in yeast studies. This can be probably speciesspecific difference or may be because of wild type nature of the DIsu. Following
addition of Fe and S together, Fe-S clusters assemble on the scaffold and
siginificantly decrease the ANS fluorescence due to stabilization of the structure
and consequent decrease in the exposure of hydrophobic residues on the protein
surface This is consistent with the well-folded structure of A. aeolicus IscU, which
was obtained by Fe-S cluster bound to the protein.
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Finally, based on the recent research in the field of Fe-S cluster assembly
formation and our results, we propose that frataxin and scaffold interact with
each other in a metal dependent manner during the assembly process. Dfh binds
iron and delivers it to DIsu during the assembly process via physically interacting
with the protein as shown by ITC. This interaction is thermodynamically
favourable based on the binding interaction data. DIsu is structurally stabilized
upon cluster binding to the protein. Our structural data suggest that the initial
iron-binding site on DIsu scaffold is separate as compared to the cysteine rich
cluster binding site. Iron transfer may take place to the active site during the
cluster formation, however this mechanism of transfer to the active cysteine is
not yet known.
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CHAPTER 3
Characterization of Poly (rC) binding protein-PCBP2
3.1

Introduction
PCBP’s were originally identified as RNA binding proteins that share a

triple KH domain configuration, characterized by high affinity and sequencespecific interaction with poly (C). PCBP’s, also known as αCP proteins (αcomplex proteins), are encoded at four dispersed loci and have additional isoforms generated via alternative splicing (56). PCBP protein family members are
involved in various biological processes such as mRNA stabilization (77-78),
translational silencing (79-80), and translational enhancement (81-82). In
addition, these proteins are found to be involved in apoptotic pathways (83-84)
and also play a role as determinants of transcriptional controls (85-86).
The PCBP protein family has recently been reported to serve as iron
chaperones for the iron storage protein Ferritin (55). Expression of human
PCBP1 and PCBP2 in yeast recovered an iron loading deficiency for human
Ferritin when it was also expressed in yeast (55). The goal of this portion of my
thesis was to identify and characterize the role of PCBP2 in cellular iron
homeostasis. My initial goal was to characterize PCBP2 and its iron binding
properties. This information will assist in reaching the long term goal of this
project, which is to elucidate the functional properties of this protein in terms of
cellular iron-homeostasis.
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3.2

Materials and Methods

3.2.1 Cloning, Optimization of Conditions for Expression of PCBP2
Human PCBP2 cDNA was supplied in pTYB11 vector by Dr. Caroline C.
Philpot at NIH. The target protein is built in frame with the N-terminus of the
intein-CBD fusion. The cDNA was amplified by transforming into amplification
cell line ΔΗ5α. Plasmid prep kit was used to extract the amplified plasmid
(Qiagen). Thus, amplified plasmid was sequenced to verify the full length protein
by GENEWIZ and sequence analysis was done using the program CLUSTALX.
The verified plasmid was transformed into BL21 (DE3) Escherichia Coli
competent cells for protein expression.
Cell growth conditions were optimized by growing cultures in different
conditions. First, the induction OD600 that gives best level of expression of protein
was determined by testing the level of expression of protein in cultures induced
at a range of OD600 (0.1-1.0). Two different concentration of IPTG (Isopropyl β-D1-thiogalactopyranoside, Sigma) 0.4, 1mM were used; two different temperature
(16, 10) °C and different growth hours (16, 20, 24,) were also explored to
determine the best condition for expression of protein (New England Biolabsimpact-kit manual).
It is very important to have a procedure that could give repeatable results
on protein expression yield. It was often encountered that the results were not
repeatable even with freshly transformed colonies. When started with freshly
transformed colony, it sometimes gave an intermediate protein yield but other
times the yield was very low even though freshly transformed colonies were used
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every time to grow culture following the same procedure. To solve this problem
and to get repeatable protein yields, double selection of high level expressing
colonies was performed (87). Nine different colonies were picked from a freshly
transformed plate and each was used to inoculate 10 ml LB (100ug/ml Amp)
taken in a sterilized Falcon tube (50ml). Each culture was grown to OD600 of ~0.6
and induced with 0.4 mM IPTG. Immediately after induction, cultures were
transferred to a shaker maintained at 16 °C and grown for 20 hours for
expression of protein of interest. After 20 hours, 1ml of the cell suspension from
each tube was spun down, cell pellet was re-suspended in SDS loading buffer for
10min at 80 °C. The level of expression was checked by running the samples on
a SDS gel. The colony showing highest level of expression was chosen and
grown to OD600 ~ 0.6. A 20 µl of cell suspension was spread onto the plate (LB +
Amp), and left in the incubator overnight at 37 °C to allow the colonies to grow.
From the plate after the 1st colony selection, eight different colonies were picked,
grown and their level of expression was tested by running an SDS page. Again,
the best expressing colony from single colony selection was grown till OD600 ~
0.6 and plated onto a (LB+ Amp) plate and allowed to grow on incubator
overnight. From the plate of 2nd colony selection, four different colonies were
picked and checked for the level of expression by running SDS-Page. Colonies
obtained after double selections were used for preparing glycerol stocks that
were used for growing cultures in the future.
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3.2.2 Purification of PCBP2
Purification of PCBP2 follows an intein-based purification scheme which is
a single step purification method. This system utilizes self splicing protein intein
in conjunction with the chitin binding domain (CBD) towards the N-terminal of
intein, whereas towards the C-terminal region it is fused with target protein. CBD
allows fusion protein (Intein + protein of interest) to bind to chitin beads (New
England Biolabs) present in the column, allowing the protein of interest to stay
bound to the column via the intein domain. Intein can be induced to undergo self
cleavage at its C-terminal peptide linkage with 1, 4-dithiothreitol (DTT) which
results in the release of target protein (88-89).
After optimization of conditions for the expression of protein, the next step
was to purify the protein for conducting the designed experiments. A solution of
10 ml LB with 100ug/ml of Amp was inoculated my glycerol stock and grown
overnight as starting culture. This overnight culture was added to 1L LB media
(autoclaved prior) with required conc. of Amp. Since the plasmid had ampresistant marker, 100 µg/ml conc. of Amp was maintained throughout the culture.
The culture was grown at 37 °C at 250 rpm, and monitored until it reached OD600
~0.6. It was then induced with 0.4 mM IPTG. After induction, the culture was
transferred to a shaker maintained at 16°C and grown for 20 hours at 250 rpm.
Cells were harvested by centrifugation for 10 minutes at 8000 rpm. Cells were resuspended in 20 mM Tris, 500 mM NaCl (pH-8.5) (5mL/g cells) in the presence
of complete EDTA free Protease Inhibitor cocktail (Roche), 1% Triton X-100 (BioRad) and final conc of 0.1 mM TCEP [tris-(2 Cyanoethyl)phosphine]. The
resuspended solution was lysed by two passes through French press to disrupt
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cell and liberate protein. The lysate was then centrifuged at high speed (21000
rpm) for 45 minutes to separate the soluble fraction from the insoluble one.
Crude soluble fraction was filtered (0.22 µm) and the lysate was then loaded in
the column packed with chitin beads (NEB). The flow was maintained at very low
speed (0.2-0.3 ml/min) to allow binding by adsorption onto the chitin column. The
immobilized fusion protein remains bound to the column with the chitin beads via
CBD. Other proteins remain freely floating in the column and can be washed
away. Column loaded with lysate was washed with ~50 column volumes of
degassed buffer “A” (20 mM Tris, 500 mM NaCl, pH-8.5), at the flow rate of 1
ml/min. To induce intein to undergo self cleavage and release target protein, 75
mM DTT (Dithiothreitol, Sigma) was added to the column. The column was left to
incubate for 30-40 hours at room temperature prior to elution.
After incubation, protein was eluted with buffer A. PCBP2 co-eluted with
N-extein,a small protein (~1.6 kDa) which can be dialyzed out by centrifuging for
buffer exchange using a 10 kDa cut off Amicons ultra centrifugal filters (Milipore).
Concentration of the protein was determined using a Lowry assay.

3.2.3 Size and Oligomeric State of PCBP2
Mass spectrometry was carried out as a next immediate step on the
purified protein to verify its mass. A 10 µM concentration of protein was used to
confirm the full length polypeptide sequence of the protein sample after
purification.
Size-exclusion chromatography was used to determine the oligomeric
state of the apo-protein. Samples were prepared in degassed buffer (20 mM Tris,
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500 mM NaCl (pH-8.5)). The same buffer was used to equilibrate, wash the
column, and also used as a running buffer. Sample was loaded with the help of
the syringe onto a 1.2 meter long column attached to AKTA system, and the
column was run at 4 °C. Protein controls of vitamin B12 (1.3 kDa), myoglobin (17
kDa), ovalbumin (44 kDa) γ-globulin (158 kDa), and thyroglobulin (670 kDa) were
used as a molecular size standards (Bio-Rad).

3.2.4 Fold and Stability of PCBP2
Circular Dichroism spectroscopy was carried out to determine the
secondary structure of the protein. Samples were prepared in 1 mM NaPi, pH-7.6
with the protein concentration of 15 µM. The experiment was performed using a
temperature regulated Olis CD spectrometer at 25 °C over the wavelength range
of 190-260 nm. A 1.0 nm resolution setup was used to record the spectrum and a
baseline was corrected by subtracting the buffer spectrum. Averaging of 10
independant scans followed by data analysis was performed using the OLIS
software analysis package.
Protein samples were heated in 5 °C increments over the temperature
range of 10 to 95 °C. Thermal unfolding curves were obtained by using 1 nm
resolution and monitoring the ellipticity at 208 and 222 nm. The protein melting
temperature (TM) was calculated by analyzing the thermal unfolding curves
obtained at 208 nm.
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3.2.5 Substrate and Protein Binding Characteristics
Isothermal Titration Calorimetry (ITC) experiments were conducted to
determine the metal binding properties of PCBP2. All protein samples and buffer
preparation of ferrous ammonium sulfate solutions were degassed on a Schlenk
line and samples were stored under Argon. Protein and aqueous ferrous
ammonium sulfate solutions were prepared anaerobically in 50 mM Tris, 150 mM
NaCl pH-7.6 (ITC buffer). ITC experiments were conducted anaerobically using a
VP-ITC titration microcalorimeter (MicroCal, Inc) at 30 °C. A 1 mM ferrous iron
solution of was titrated into a 1.4 ml volume of 30 µM protein solution. The initial
2 µl injection was followed by 29 additional 10 µl injections that were titrated into
the protein solution. The interval between two injections was 10 min, and the
stirring speed of the syringe was held constant at 502 rpm. All data were
conducted in triplicate on independent protein and iron samples to ensure data
reproducibility. Data analysis was performed using the Origin 7.0 Scientific
Graphing and Analysis Software (provided by Micro Cal) to determine the binding
affinity and metal-protein stoichiomety.
The binding affinities of other metals such as Zinc were also tested.
Samples were prepared in 50 mM Tris, 200 mM NaCl (pH-7.6) and degassed. A
1 mM Zinc solution was titrated as an initial 2 µl injection, followed by 29
additional 10 µl injections, into 1.4 ml of a 25 µM degassed protein sample. The
experiment was conducted at 30 °C at a stirring speed held constant at 502 rpm
with 10 min interval between injections. The obtained data was analyzed using
the software provided by Micro Cal.

50
Characterization of the interaction between PCBP2 and Ferritin was also
conducted using ITC. Samples were prepared in ITC buffer, 150 µM Ferritin was
titrated to 1.4 ml of 15 µM apo-PCBP2. Both protein samples were degassed in
the Schlenk line prior to loading. The experiment was conducted at 30 °C with
the stirring speed of 502 rpm. Similarly, the interaction between holo-PCBP2
binding to H-chain Ferritin (Horse spleen-Sigma) was tested. Holo-PCBP2
samples were prepared anaerobically in a glove box, with the metal protein
stoichometry of 3:1 (600 µM:200 µM). The 200 µM holo PCBP2 sample was
titrated into 1.4 ml of 20 µM H-chain Ferritin and the experiment was conducted
at 30 °C at 502 rpm.

3.2.6 XAS Sample Preparation and Analysis
X-ray absorption spectroscopy was utilized to investigate the electronic
characteristics and ligand co-ordination geometry of iron bound to PCBP2. XAS
samples were prepared in 50 mM Tris, 150 mM NaCl (pH-7.6) and 30% glycerol.
Multiple independent holo-PCBP2 samples were prepared anaerobically in a
glove-box (PlasLabs) purged with argon(at a Fe:PCBP2 ratio of 1:1 and 3:1)
using protein samples and iron solutions that were degassed initially in the
Schlenk line and stored under an argon atmosphere. Samples were loaded in
Lucite XAS cells wrapped with Kapton tape, flash frozen immediately after
loading, removed from glovebox and stored immediately in liquid nitrogen until
they were used.
XAS data were collected at the Stanford Synchrotron Radiation Laboratory
(SSRL) on beamline 9-3. Beamline 9-3 was equipped with a Si (220) double-
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crystal monochromator and harmonic rejection mirrors. During data collection,
samples were maintained at 10K using an Oxford Instruments continuous-flow
liquid helium cryostat. Protein fluorescence excitation spectra were collected
using ionization detectors filled with nitrogen gas, placed before and after the
cryostat. XAS spectra were measured using 5 eV steps in the pre-edge region
(6900-7094), 0.25 eV steps in the edge region (7095-7135) and 0.05 Å-1
increments in the extended X-ray absorption fine structure (EXAFS) region (to
k=13.5 Å-1 ), integrating from 1 to 20 s in a k3 weighted manner for a total scan
length of approximately 40 minutes. X-ray energies were calibrated by recording
an iron foil absorption spectrum simultaneously with the collection of the protein
data. The first inflection point for the iron foil edge was assigned at 7111.3 eV.
Each fluorescence channel of each scan was examined for spectral anomalies
prior to averaging and spectra were closely monitored for photo-reduction. SSRL
data represent average of 100 scans.
XAS data was processed using the Macintosh OS X version of
EXAFSPAK manual suite integrated with Feff version 7.2 for theoretical model
generation (90-91). Data reduction and processing of the pre-edge transitions
utilized a Gaussian function in the pre-edge region and a three-region cubic
spline in the EXAFS region. EXAFS data was converted to k-space using an E0
value of 7130 eV. Data was truncated at 1.0 and 13.5 Å-1 for filtering purposes
and Fourier transformed. Fitting analysis was performed on raw/unfiltered data
and Fourier transformed. A scale factor (Sc) of 0.95 and threshold shift (ΔE0) of 11.5 eV were used during the data analysis. The Sc and ΔE0 were not allowed to
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vary as they were calibrated from the Fe(II) model compounds matching the
oxidation state of the ferrous iron. When simulating empirical data, metal-ligand
coordination numbers were fixed as a half integer values while only the absorberscatterer bond length (R) and Debye-Waller factor (σ2 ) were allowed to vary
freely. The criteria for judging the best fit simulation, and for adding ligand
environment to the fit, included: A) the lowest mean square deviation between
data and fit (F’), a value corrected for number of degrees of freedom in the fit, B)
individual shell bond distances must be outside the spectral resolution (> 0.13 Å)
and finally C) all Debye- Waller factors in the ligand system must have values
less than 0.006 Å2 (92).
Analysis of X-ray absorption near edge spectroscopy (XANES) 1sÆ3d
transition was completed using the EDG_FIT subroutine with EXAFSPAK (90).
The data was compared with Fe(II) and Fe(III) models and edge analysis was
performed in Kalaiedograph.

3.3

Results

3.3.1 Optimization of Condition for Expression of Protein
The level of expression of the colonies under different growth condition
was explored. The different growth conditions explored are listed in Table 3.1.
Comparing the level of expression of protein, it was concluded that apo-PCPB2
expresses best when grown at 16 °C for 20 hours after induction with 0.4 mM
IPTG. The level of expression when induced at different OD600 values are shown
in Figure 3.1, (Panel A). The lanes from 3-10 show levels of expression when
induced at different OD600. Best level of protein expression was obtained when
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the culture was induced at OD600 0.6, as shown in lane 8 (Figure 3.1, Panel A).
Similarly, higher yields of protein expression were obtained when grown for 20
hours after induction as shown in lane 4 (Figure 3.1, Panel B).

Figure 3.1. SDS-Page showing the level of expression of apo-PCBP2, when induced at
different OD600. Panel A: Expected protein band (apo PCBP2+ intein) ~95kDa is shown with
an arrow. Induction OD600 lanes 3-10 are 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, 1.0 respectively.
Panel B: shows level of expression of apo-PCBP2 when grown for 16, 20 and 24 hours
after induction (lanes 3-5 respectively).

To obtain dependable yields of the protein double colony, selection of the
best expressing colony was performed. Figure 3.2 (Panel A) shows a weak level
of expression of protein of nine different freshly transformed colonies (Lanes 210, Panel A, Figure 3.2). The best expressing colony (Lane 4, Panel A Figure
3.2) was selected and plated on a (LB + Amp) plate. Eight different colonies
obtained from single colony selection were tested for level of expression (Panel
B, lanes 2-10 ,Figure 3.2). The level of expression after single colony selection
was higher compared to the freshly transformed colonies. Again, the best
expressing colony in Panel B (lane 9, Figure 3.2) was selected and plated. The
level of expression of four different colonies, after double colony selection, is
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shown in Panel C (Lanes 3-6, Figure 3.2). After the colonies were selected for
the second time, protein was expressed in higher levels compared to the freshly
transformed colonies. These colonies were used for preparing glycerol stocks
which were used for growing cultures. Double selection of the high expressing
colony produced repeatable results in the yield of protein every time the protein
was purified.

Figure 3.2. SDS-PAGES of protein expression of apo-PCBP2 (365aa) before (Panel A),
during (Panel B), and after (Panel C) double colony selections. Expected protein band (~95
kDa, apo PCBP2 (1-365)+ intein) are observed. Panel A shows expression of nine different
colonies before colony selection. Panel B shows result of 8 colonies after single colony
selection (3rd lane-from Panel A) because this colony gave good level of expression. Panel
C shows the results of four colonies selected after double colony selection (lane, 9-from
Panel B), indicating high level of protein expression. Molecular weight markers are labeled
with kDa. Lane 2 in both panels (B, C) are pre induced samples).
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Table 3.1. Different conditions for optimization of expression of PCBP2.

3.3.2 Purification of PCBP2
Purification of PCBP2 follows affinity purification, by which pure protein
can be obtained in a single step. PCBP2 is cloned in frame with a self-splicing
intein domain that allows it to bind to the chitin beads present in the column.
Upon induction with DTT, intein cleaves itself and remains immobilized on the
chitin resin with the release of the target protein along with another small protein
(~1.6kDa) which cannot be seen on the gel and can be dialyzed away. Figure 3.3
shows the steps on purification of PCBP2. After optimization of conditions,
PCBP2 was purified in a single step with ~ 95% purity and 5-8 mg/L yield. Protein
concentrations were measured by the Lowry assay before conducting the
designed experiments.
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Figure 3.3 SDS-Page showing purification of apo-PCBP2. Protein marker was loaded in
first lane and labeled with kDa. Lane 2-pre induction sample, Lane 3- post induction
sample, Lane 4, 5 –supernatant and pellet samples respectively. Lanes 2-4 shows fusion
protein band (apo-PCBP2+intein), 6-7 are elution’s showing apo-PCBP2. Lane 8 shows 3
bands; fusion protein, intein, and apo-PCBP2 respectively.

3.3.3 Size and Oligomeric State of PCBP2
This 365 amino acid protein was expressed in bacteria (5-8 mg/L of
medium). Mass spectrometric analysis of apo-PCBP2 indicated the molecular
mass of 38,578.4 ± 5 Daltons, Figure 3.4, Top panel. Expected mass of full
length apo-PCBP2 (Isoform d, 365 amino acids) from the sequence is 38,580
Daltons. Mass spectrometric results showed that full length protein is purified in
a single step and PCBP2 elutes out from the column without loss or gain of any
additional amino acids.
The oligomeric state of the protein was determined by loading a 200 µM
sample onto a size exclusion column (Sephacryl-200) and collecting 2 ml
fractions, which were tested for protein by the quick advanced assay (Biorad).
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Figure 3.4. A Determining molecular weight and Oligomeric state of PCBP2. The peak was
observed with molecular weight 38,580±2 Daltons, which is the molecular weight of full
length PCBP2. It showed that PCBP2 is successfully purified with full length protein (Top
panel). PCBP2 elutes as a dimer in size-exclusion column. Sample was run through S-200
column, and elution peaks were observed. 4 peaks were observed for standards which
were compared with the peaks observed for the protein (Bottom panel). First peak,
observed in the void volume did not show the any bands showing protein (lanes 5-7).
Second peak observed showed protein bands on gel(lanes 2-4), which elutes as a dimer
52-56ml (70±7kDa).
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The fractions that gave positive results in the Biorad assay were run on a SDS
gel to confirm the presence of protein in those samples (Bottom Panel, Figure
3.4). Two peaks were observed: a first peak between 30-40ml (void volume of
column) and a second peak observed between 52-56 ml. The graph suggests
that the protein elutes at 52-56 ml. This was verified by running the samples on
SDS-Page (Lanes 2-4, Bottom panel, Figure 3.4). The molecular weight range
falls between 70±7 kDa, when compared with the standards, suggesting the
protein exists as a dimer. Lanes 5-7 (Bottom panel, Figure 3.4) are the samples
taken from the fractions collected between 30-40 ml, which does not appear as a
protein band in SDS-page. Elution peaks observed in the range of void volume
may be the aggregates of the protein and these eluted out as early fractions.

3.3.4 Fold and Stability of PCBP2
Secondary structure analysis by CD spectra showed that PCBP2 has a
high helical content. CD spectral simulations suggested an approximate
secondary structure distribution of 59% α-helix, 16% β-sheet and 25%
turns/coils, (Standard Deviation: 0.11) (Figure 3.5 A).
A melting temperature for PCBP2 was determined using CD spectroscopy
(Figure 3.5 B). Full CD spectra for PCBP2, covering the wavelength range of
190-260 nm, were collected over a broad temperature profile to generate a
thermal denaturation plot. The thermal profile was determined by measuring
changes in molar ellipticity at both 208 and 222 nm. A representative plot of
temperature-dependent fractional fold of the protein utilizing the 10 and 95 °C
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spectra as limits is given for the 208 nm signals in the Figure 3.5 B. The melting
temperature of the protein was calculated to be 56 ± 2.5 °C.

.
Figure 3.5. (A) Secondary structure of PCBP2 determined by Circular Dichroism
Spectroscopy at 25°C in 1mM NaPi (pH-7.6). The displayed spectrum represents an
average of 10 consecutive scans. Analysis of the spectrum showed PCBP2 is a folded
protein with mainly helical content. Observed secondary structure percents were 59% αhelix, 19% β-sheet, 25% coils/turns (B) The thermal denaturation curve was obtained by
measuring changes in molar ellipticity at 208 nm from the CD spectra of protein samples
taken at multiple temperatures (10-95 °C) with 5° increment between samples. The dots
represent raw data which were simulated using Kalaeidograph. Melting temperature of the
protein was determined to be 56±2.5 °C.

3.3.5 Metal Binding Properties of PCBP2
Isothermal Titration Calorimetry (ITC) was used to characterize the ferrous
iron binding affinity and maximal metal:protein stoichiometry of iron to PCBP2. A
change in the heat associated with titration of anaerobically prepared ferrous iron
to apo-PCBP2 is shown as raw ITC data. Raw ITC shows the binding event is an
exothermic process since the heat released upon titration being negative. The fit
shows that PCBP2 binds iron at two binding sites, one tighter than the other. The
first binding site is occupied with 1.46±0.1 Fe atoms with a binding affinity of
0.034 ± 0.023 µM, while the second binding site is occupied with 2.05 ± 0.09 iron
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atoms with the binding affinity of 0.64 ± 0.1 µM. The first metal binding event was
enthalpically favorable (ΔH1 = -12.2 kcal/mol) and entropically unfavorable (ΔS1 =
-5.32 cal/mol) with overall favorable free energy (ΔG1 = -12.205 kcal/mol). Metal
binding to the second site was ethalpically favorable (ΔH2 = -6.73 kcal/mol) and
entropically favorable (ΔS2 = 6.11 cal/mol) as well with overall favorable free
energy (ΔG2 = -6.72 kcal/mol) Figure 3.6, A.

Figure 3.6. PCBP2 is a metal binding protein. (A) Exothermic profile of heat released
obtained upon titration of ferrous iron to PCBP2. PCBP2 binds iron at 2 binding sites at
micro-molar binding affinity. (B) PCBP2 also binds Zinc, with slightly higher affinity
compared to iron.

Further binding of PCBP2 to divalent metal Zinc was also explored. A 1
mM ZnCl2 solution was prepared in 50 mM Tris, 200 mM NaCl (pH - 7.6) and
titrated into 25 µM PCBP2 at 30 °C generated an exothermic profile of heat
released. The fitting analysis showed PCBP2 binds 2.08 ± 0.05 Zn atoms with
the binding affinity of 9.0 ± 6.6 µM. Metal binding event was enthalpically
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favorable (ΔH = -8.6 kcal/mol) and entropically unfavorable (ΔS = -5.81 cal/mol)
with overall favorable free energy ΔG = -8.61 kcal/mol. (Figure 3.6, B)
Similarly, interaction of PCBP2 to ferritin was also conducted by using
ITC. Titration of Ferritin to apo-PCBP2 did not generate a heat release profile
suggesting that these two proteins do not interact in the absence of iron (Figure
3.7, A). Titration of holo-PCBP2 to Ferritin generated an exothermic profile in the
raw data suggesting a binding event is taking place between Ferritin and PCBP2
in the presence of iron (Figure 3.7, B). Preliminary data suggest the binding
process, binding affinity and stoichiometric ratio of Ferritin bound to PCBP2 still
needs to be explored with varying buffer conditions to get better data.

Figure 3.7. Interaction of Ferritin with apo/holo-PCBP2. (A) PCBP2 does not interact with
Ferritin in the absence of Iron. (B) Exothermic profile of heat release is obtained upon
titration of holo-PCBP2 to Ferritin.
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The interaction between PCBP2 and Ferritin in the presence of iron is
supported by a previous study conducted with the family member PCBP1, where
PCBP1 and Ferritin were co-immunoprecipitated only in the presence of iron
(55). However, exact binding parameters are yet to be explored.

3.3.6 Electronic and Coordination Properties of Bound Iron
XAS studies were conducted to characterize the electronic and structural
properties of iron bound to PCBP2. K-edge XANES spectra for holo-PCBP2,
compared to Fe(II) and Fe(III) controls (35) are given in Figure 3.8. The edge
feature of bound iron resembles those observed for our aquaous Fe (II) control.
The first inflection edge energy for iron bound to PCBP2 closely matches that
obtained for the Fe (II) control (7122.42 ± 0.05 eV and 7123.1 ± 0.06 eV,
respectively) as compared to the value obtained for the Fe (III) control (7127 ±
0.02 eV), indicating PCBP2-bound iron is stable as ferrous metal.
EXAFS analysis was used to provide the metal-ligand metric parameters
for ferrous iron bound to PCBP2. Raw EXAFS data for Fe:PCBP2 (1:1), has a
maximum amplitude of 5.5 Å-1 with the single frequency pattern suggesting the
nearest neighbor environment of the Fe-bound to PCBP2 consists of oxygen
and/or nitrogen based ligand environment (Figure 3.9, black lines). Spectral
simulations showed ligands that directly coordinated with Fe(II) consisted of
completely oxygen/nitrogen based environments(Table 3.2). The data is a best fit
using 2 O/N shell nearest neighbor environment in the simulations (Fig 3.9, green
lines). The sample showed a partially disordered ligand environment with total
co-ordination number ~6 as expected for the octahedral symmetry generally seen
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for ferrous iron. There were no evident iron-sulfur ligation and no long range
scattering of atoms were observed.

Figure 3.8. XANES comparison of iron loaded PCBP2 with ferrous and ferric models. Full
XANES spectra for PCBP2 with 1 iron bound (blue-solid), ferrous ammonium sulfate (red
dashed line) and ferric ammonium sulfate (black dotted line) are displayed. XANES
analysis of iron bound to PCBP2 showed pre-edge features that resemble the ferrous
ammonium sulfate model.
Table 3.2 XAS best fit values for Fe(II) bound to PCBP2.
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Figure 3.9. EXAFS and Fourier transforms of iron loaded human PCBP2 XAS data. Raw
EXAFS spectra (in black) of protein with 1 iron bound, along with corresponding Fourier
transform. Simulations of EXAFS and Fourier transform are shown in green.

3.4

Conclusion and Discussion
Uptake of the iron by our body is in milligram range and hence it is

considered as a micronutrient (93). Even though this requirement is only in the
low milligram range, iron is utilized in almost all biological processes including
DNA synthesis, oxygen transport, and cell division (94). Despite the low dietary
requirement, iron deficiency is a major global health problem affecting more than
2 billion people worldwide, and it is listed in the group of the top ten leading risk
factors for health impairment by World Health Organization (95). As stated in a
recent American Heart Association Scientific sessions (2009), “treatment of iron
deficiency improves symptoms, functional capacity and quality of life in chronic
heart failure patients, independent of presence of ammonia”. Similarly, excess of
iron is also detrimental to health, due to of its ability to form metal based reactive
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oxygen species (ROS) that destroy cellular DNA and compromises cellular
efficacy. Hemochromatosis, along with other iron related disorders such as
Friedrich’s Ataxia, Parkinson’s disease, and Alzheimer’s are reported to be
associated with dysregulation of iron metabolism (96-99).
Proper level of iron must be balanced in the body to ensure cell can utilize
iron when it is needed and to protect themselves against the harmful effects of
unregulated metal. Metallochaperones play a vital role in maintaining cellular
homeostasis to accommodate these homeostatic requirements. These metallochaperones bind metal and deliver it to cognate enzymes that require it (100).
Identification of a cytosolic iron chaperone has helped to solve one piece of the
puzzle of cellular iron homeostasis and provided new insight for the study of
many iron-dependent enzymes in the cytosol. The PCBP family of proteins,
which were initially recognized as RNA binding proteins, are identified as
players in cellular iron metabolism and serve to deliver iron to cytosolic iron
storage protein Ferritin (55). However, the mechanism of iron transport in terms
of cellular iron homeostasis and the role played by the PCBP family of proteins
is yet to be unfolded.
This thesis studies the biophysical properties of PCBP2 and its metal
binding properties. It was found that PCBP2 is a folded protein with high helical
content, and Melting Temperature (TM) of 56 ± 2.5 °C. With respect to its metal
binding properties, it was found that PCBP2 binds iron with micromolar binding
affinity. This interaction is iron dependent. Also, it has been shown that there is
no interaction between the family proteins (PCBP1 and PCBP2) in the absence
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of iron. The interaction between PCBP’s in the presence of iron is yet to be done.
Further, the electronic properties of iron (bound to PCBP2) shows the metal is
bound in an O/N based ligand environment in the Fe(II) form.
Given that PCBP binds iron, identification of active sites for metal binding
via site directed mutagenesis will further help to decipher the role of PCBP’s in
iron homeostasis.
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CHAPTER 4
Activation of the HIF Prolyl Hydroxylase by the Iron Chaperones PCBP1
and PCBP2

4.1

Prelude
Since free iron is very reactive and can lead to the formation of reactive

oxygen species (ROS), iron must be properly regulated so that the body gets iron
when and where it is required and at the same time saves itself from the toxic
effects of iron. Identification of Poly (rC) Binding Protein 1 (PCBP1) as a cytosolic
iron chaperone confirms that the PCBP family of proteins are involved in iron
homeostasis in the cytosol. The PCBP family of proteins have been proposed to
also serve as iron chaperones for other cytosolic proteins that require iron. There
are many iron-dependent enzymes in the cytosol, which may interact with
PCBP’s. In a final project, we studied the role of PCBP’s with respect to iron
delivery

to

the

Prolyl-hydroxylase-2

enzyme.

My

contribution

to

the

corresponding work is related only to the purification of PCBP2 and supplying the
protein for studies. I have purified apo-PCBP2 (365 aa) and supplied for
conducting the designed experiments.
In detail, this manuscript studies the role of PCBP1 and PCBP2 with
relation to Prolyl-hydroxylase-2 activation. A manuscript covering this work is
currently under preparation for publication, and the manuscript reference is:
Anjali Nandal, Julio C. Ruiz, Poorna Subramanian, Sudipa Ghimire-Rijal, Ruth
Ann Sinnamon, Timothy L. Stemmler, Richard K. Bruick, and Caroline C.
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Philpott, “Activation of the HIF Prolyl Hydroxylase by the Iron Chaperones
PCBP1 and PCBP2” 2011, In preparation.

4.2

Introduction
Mammalian cells express hundreds of metalloproteins. Most of them

contain the abundant metals iron and zinc, while others contain various trace
metals, such as copper, manganese, molybdenum and cobalt (101). These
metals are essential nutrients because metal cofactors activate enzymes and
proteins that perform critical functions in virtually every major cellular process
(102). Several factors complicate the incorporation of the correct metal ion into a
metalloprotein. First, the binding sites for different metals within metalloproteins
can be structurally very similar, and incorporation of the non-cognate metal ion is
easily achieved in vitro for many of these proteins. Second, pools of “free” metal
ions in cells may be vanishingly small, as most zinc and copper ions are tightly
bound to cytosolic proteins (103). Third, redox-active metals, such as iron and
copper ions, can catalyze the production of damaging reactive oxygen species,
and cells must maintain tight control over these metals in order to use them while
simultaneously avoiding their toxic effects. Fortunately, the majority of
metalloproteins receive the correct metal ion in vivo, as incorporation of the
wrong metal ion typically inactivates the protein.
Although the incorporation of the appropriate metal ion(s) into cellular
metalloproteins is a critical, essential process, the mechanism by which most
metalloproteins receive their cognate ligand is unknown. Some proteins rely on
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metallochaperones: proteins that specifically bind metal ions and deliver them to
target enzymes and transporters through direct protein-protein interactions (104).
Metallochaperones delivering nickel and copper have been described in
prokaryotes and eukaryotes, but much less is known about the delivery of iron
and zinc. Frataxin, the protein lacking in the neurodegenerative disease
Friedreich’s Ataxia, is a mitochondrial protein that functions as an iron chaperone
for the assembly of iron-sulfur clusters (105).
More recently, we identified poly (rC) binding protein 1 (PCBP1) as a
cytosolic iron chaperone that delivers iron to ferritin (55). In mammals, ferritin is a
heteropolymer consisting of 24 subunits of heavy (H) and light (L) peptides that
assemble into a hollow sphere into which iron is deposited (106-107). Ferritin
serves both to sequester cytosolic iron when it is present in excess and to store
iron to meet metabolic needs during periods of iron scarcity. PCBP1 binds Fe(II)
with micromolar affinity in a 3 Fe: 1 PCBP1 molar ratio. PCBP1 binds ferritin in
vivo and can enhance iron incorporation into ferritin in vitro and in vivo.
Mammalian cells lacking PCBP1 exhibit defects in the incorporation of iron into
ferritin as well as an increase in the labile pool of cytosolic iron.
PCBP1 (also called α-CP1 or hnRNP E1) has previously been found to
function as a RNA and DNA binding protein (56, 108-109). PCBP1 is one
member of a family of four homologous proteins containing three heterogeneous
nuclear ribonucleoprotein K-homology (KH) domains, an ancient and conserved
RNA binding module. PCBP1, an intronless gene, likely arose from the
retrotranspositon of a splice variant of PCBP2 mRNA, and became fixed in the
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genome because it encoded a unique function not shared by the other PCBPs.
PCBP1 and 2 bind to cytosolic and viral RNAs, thereby affecting their translation
or stability. PCBPs also have a role in transcriptional regulation and participate in
several protein-protein interactions.
Numerous cellular proteins require iron for activity. Iron in the form of
heme and iron-sulfur clusters are cofactors for proteins involved in a host of
metabolic and regulatory functions. Enzymes of the “non-heme” iron families
directly coordinate iron ions as cofactors. These families include the diiron
monooxygenases, such as the δ-9-fatty acid desaturase and the small subunit of
ribonucleotide reductase (110). A second family is the Fe(II)- and 2-oxoglutarate
(2-OG)-dependent dioxygenases (111-113). This family is a large, evolutionarily
conserved class of enzymes that can oxidatively modify a variety of substrates.
In mammals, four members of this class regulate the activity of the transcription
factors that control the mammalian response to hypoxia.
Hypoxia-inducible factor (HIF) is a heterodimeric transcription factor that
binds DNA at specific sites, termed hypoxia response elements (HREs), and
activates the expression of more than 100 genes involved in the adaptation to
reduced oxygen levels (111-113). Under hypoxic conditions, the alpha subunit
(HIFα) accumulates and binds to the beta subunit (HIF1β, also called ARNT) to
form the active transcription factor. Metazoans express three unstable HIFα
subunits. Under conditions of normoxia or hyperoxia, HIF1α is hydroxylated on
proline residues 402 and 564, which allows the protein to be recognized by the
von Hippel-Lindau tumor suppressor protein (pVHL), thus targeting HIF1α for
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ubiquitin-mediated degradation in the proteasome (114-115). Three HIF prolyl
hydroxylases, PHD1, 2, and 3 (also called HPH-3, -2, and -1 or EGLN2, 1, and 3,
respectively) mediate the hydroxylation of proline residues on HIF1α (116-117),
although PHD2 is responsible for nearly all (>95%) of the activity in cells (118).
HIF1α is also hydroxylated on asparagine 803 by an asparaginyl hydroxylase,
factor inhibiting HIF (FIH1) (119-120), a modification that inhibits the association
of transcriptional coactivators (121). The activities of the HIF hydroxylases are
regulated by the availability of the co-substrates, 2-OG and oxygen. Because the
hydroxylases exhibit changes in oxygen binding and activity over the range of
oxygen concentrations present in tissues, these enzymes are hypothesized to
function directly as oxygen sensors.
The activities of the HIF hydroxylases may also be regulated by the
availability of iron. HIF hydroxylase activity is stimulated by the addition of Fe(II)
in vitro, and, in cultured cells, activity is inhibited by iron chelators (111). In mice,
HIF2α accumulates in duodenal enterocytes in response to iron deprivation,
which may reflect a localized decrease in HIF hydroxylase activity (122). Cellular
factors that control the incorporation of iron into the HIF hydroxylases are
unknown.
Here we have addressed the question of whether PCBP1, or its paralog
PCBP2, is involved in the delivery of iron to the Fe(II)-dependent prolyl
hydroxylases regulating HIF. We found that cells lacking PCBP1 and, to a lesser
extent, PCBP2, exhibited increased levels of HIF1α that was due to a decrease
in prolyl hydroxylation and VHL-mediated degradation. The loss of prolyl
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hydroxylase activity was traced to a decrease in iron loading of the enzyme,
which could be restored with recombinant PCBP1. PCBP1 physically interacted
with PHD2, indicating that PCBP1 acts as an iron chaperone for PHD2. Our
studies also suggest a role for PCBPs in the activation of the asparaginyl
hydroxylase FIH1, as well.

4.3

Experimental Procedures

4.3.1 Cell culture and treatments
Huh7, A549 and HEK293T cells were grown in high glucose Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum and
antibiotics (penicillin G, 50 U/ml, and streptomycin, 50 µg/ml) (Gibco-BRL). Cells
were treated, as indicated, with the following agents: cycloheximide, ferric
chloride, desferrioxamine B (DFO) and MG132, all purchased from Sigma.

4.3.2 Protein depletion by siRNA
PCBP1 and 2 were depleted using Stealth Select RNAi (Invitrogen) with
the sequences found in Table S1. A non-targeting, scrambled sequence siRNA
pool was used as a control. Huh7 or A549 cells were transfected with 50 pMol of
siRNA using Lipofectamine RNAiMAX (Invitrogen). Cells were harvested at 3
days after transfection for maximal PCBP1 and 2 depletion. In the HEK293T cell
line, two sequential transfections spaced 24 hr apart with the PCBP1 and 2
siRNAs were performed to obtain maximal depletion.

4.3.3 RNA extraction and Real-time PCR
RNA was isolated from cells using the RNeasy RNA Isolation kit according
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to the manufacturer’s instructions (Qiagen). For reverse transcription, 1 μg of
total RNA was used in a reaction mixture containing dNTPs and superscript II as
per the manufacturer’s instructions (Invitrogen). Reverse transcription was
performed for 10 min at 25 °C, 60 min at 42 °C, and 5 min at 70 °C using the
PTC200 gradient cycler (MJ Research). Quantitative real-time PCR was
performed using the double-stranded DNA dye SYBR Green (Applied
Biosystems) on an ABI 7500 system according to the manufacturer’s protocols.
Experiments were performed in triplicate. The primers used are found in Table
S2. The HIF1α, HIF2α and PHD2 values were normalized to β-actin according to
Pfaffl’s mathematical model for relative quantification in real time PCR (123).
Actin quantitation did not vary with siRNA or DFO treatment.

4.3.4 Immunoblot analysis
Nuclear and cytoplasmic extracts were prepared using the nuclear extract
kit (Active Motif) according to the manufacturer’s instructions. Nuclear extracts
were used for HIF and CREB Western blots. Membranes were probed using
mouse anti-HIF1α (Transduction, 1:1000), rabbit anti-HIF2α (GeneTex, 1:1000),
or mouse anti-CREB (Cell Signaling, 1:1000) antibodies. For detection of
hydroxylated HIF1α, A549 cells were cultured in DMEM and PCBPs were
depleted using siRNAs as described above. After 72 hr, 100 µM MG132 was
added for 6 hr followed by 25 µM DFO for 2 hr Nuclear extracts (40 µg) were
analyzed by Western blotting with a rabbit antibody that specifically recognizes
HIF1α hydroxylation at proline 564 (gift of O. Aprelikova). Whole cell lysates or
cytoplasmic extracts were used for all other Western blotting experiments. Whole
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cell extracts were prepared by lysis with buffer A [25 mM Tris (pH 8), 1% Nonidet
P40, 0.1% Triton, 1 mM DTT, 1X protease inhibitor cocktail (Roche) and 40 mM
KCl]. Membranes were incubated with the indicated primary antibodies, followed
by detection with horseradish peroxidase-linked secondary antibodies and
enhanced chemiluminescence substrates (Pierce). Antibodies used for Western
blotting were rabbit anti-PHD2 (Novus Biologicals), mouse anti-PCBP2 (Novus
biologicals), mouse anti-HA (Covance), and horseradish peroxidase-conjugated,
mouse anti-FLAG (Sigma). Horseradish peroxidase-conjugated secondary
antibodies (Amersham) were used at 1:1000. Antibody against recombinant
human PCBP1 (55) was raised in chickens and purified from yolks by the
manufacturer (Covance) and used at 1:2000-1:5000.

4.3.5 Luciferase activity assays
HeLa 3XHRE Luc cells (124) were cultured and PCBP1 and/or PCBP2
were depleted as described above. Firefly luciferase activity was assayed using
Dual Luciferase reporter assay system (Promega). Samples were read in Lumat
LB9507 luminometer (Berthold Tech). For FIH activity, PCBPs were depleted in
HEK 293 cells, then plasmids encoding the GalDBD/HIF2α CADs, G5E1b-Luc
reporter, pcDNA3.1-FIH1, and pRL-TK were transfected for 18 hr prior to
measurement of luciferase activity. Activity was reported as the ratio to renilla
luciferase control.

4.3.6 HIF half-life determination
Huh7 cells were transfected with control or PCBP1 and 2 siRNAs for 3
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days then were treated with 25 µM DFO for 2 hr. Cycloheximide was added at 60
µg/ml, and the cells collect at intervals. HIF1α was analyzed in nuclear extracts.

4.3.7 VHL capture assay
HEK293T cells were grown and PCBP1, 2 or both were deleted after
sequential transfections of their siRNAs. The cells were lysed by sonication for 5
min. HA-pVHL was synthesized by in vitro transcription/translation reactions
using TNT T7 Quick Coupled Rabbit Reticulocyte Lysate kit (Promega). The VHL
capture assay was performed as described (125-126).

4.3.8 PHD2 activity assay
Biotinylated

peptides

derived

from

the

HIF1α

oxygen-dependent

degradation domain [Biotin-Acp-DLDLEALAPYIPADDDFQL or a hydroxylated
control

Biotin-Acp-DLDLEALAP(OH)YIPADDDFQL]

were

immobilized

on

Neutravidin-coated 96-well plates. A549 cells were grown and PCBP1 and/or 2
were depleted using siRNA. The cells were harvested and resuspended in 1 ml
hypotonic buffer (20 mM Hepes, 5 mM NaF, 10 μM Na2MoO4 or Na3VO4, 0.1 mM
EDTA, protease inhibitor cocktail and 2 mM DTT) for 15-20 min, then 0.5% NP40 was added and the samples were vortexed for 10 sec. Clarified lysates (50
µg/well) were incubated in reaction buffer containing 20 mM Tris-Cl (pH 7.5), 5
mM KCl, 1.5 mM MgCl2, 2 mM DTT, 0-100 μM ferrous sulfate, 0.5 mM 2-OG and
1 mM ascorbate for 45 min at room temperature. Purified recombinant PCBP1 or
albumin (30 µM) was loaded with 100 μM ferrous sulfate for 2 hr at 4°C in an
anoxic chamber (Coy Laboratories), then added to lysates at a final
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concentration of 3 µM protein/10 µM Fe(II). Peptide hydroxylation was detected
using a polyclonal rabbit antibody raised against a hydroxylated HIF peptide
epitope, followed by addition of a goat anti-rabbit HRP-conjugated secondary
antibody (Santa Cruz). Luminescence was measured in an EnVision plate reader
(Perkin Elmer).

4.3.9 Immunoprecipitation
HEK293T cells were depleted of PCBPs, then grown and labeled
overnight with addition of 2 μM of
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Fe(II):NTA (1:4 molar ratio). For

overexpression of PHD2, cells were transiently transfected with pcDNA3-PHD2FLAG (1 μg). The cells were lysed in buffer containing 50 mM Tris-HCl, pH 7.5;
150 mM NaCl, 0.5% NP40 and protease (Sigma) and phosphatase inhibitors
(Pierce). PHD2 was immunoprecipitated with 5 μg of anti-PHD2 antibody (Novus
Biologicals) in 1.5 mg lysate overnight followed by protein A dynabeads
(Invitrogen) for 3-4 hours at 4oC. The beads were then washed retained
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Fe

measured by scintillation counting (LS6500, Beckman Coulter). For coimmunoprecipitations, anti-PCBP1 antibody or bulk chicken IgY (Gallus
Immunotech) was coupled to magnetic M280 tosylactivated dynabeads
(Invitrogen) using 100 μg of antibody. Beads were then blocked in 0.5% BSA and
washed with PBS (pH 7.4) containing 0.1% BSA prior to use. HEK293T cells
were treated overnight with either ferric chloride (20 μM) or DFO (100 μM). The
cells were harvested and lysed in buffer A and lysates (1.5 mg for PHD2
overexpression, 3 mg for untransfected cells) were incubated with beads,
washed, and the immune complexes analyzed by Western blotting.
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4.4

Results

4.4.1 Accumulation of transcriptionally active HIF1α in cells lacking
PCBPs
The activity of the Fe-dependent prolyl hydroxylases is reflected in the
abundance of HIF1α protein. HIF1α from nuclear extracts was barely detectable
in Huh7 cells grown under normoxia, but was greatly increased in cells treated
for 16 hr with the iron chelator desferrioxamine B (DFO) due to the inhibition of
the prolyl hydroxylases (Fig. 4.1A). We examined the effects of PCBP depletion
on HIF1α levels by transfecting Huh7 cells with small interfering RNAs (siRNAs)
directed against PCBP1 and PCBP2, and with a control siRNA. Depletion of
PCBP1 resulted in a three-fold increase in HIF1α protein when compared to the
cells treated with control siRNA, without a significant change in HIF1α levels in
cells treated with siRNAs against PCBP2 and PCBP1 and 2 together (Fig. 4.1A
and B). We hypothesized that cells subjected to a mild iron deficiency might
show increased sensitivity to PCBP depletion, and briefly treated cells depleted
of PCBPs with DFO then examined the levels of HIF1α (Fig. 4.1C and 4.1D).
When compared to cells treated with control siRNA, cells depleted of PCBP1
exhibited a 7-fold increase in the level of HIF1α. Cells depleted of both PCBP1
and PCBP2 exhibited similarly high levels of HIF1α, while cells lacking only
PCBP2 exhibited a small and variable increase in HIF1α levels. We measured
the effects of the siRNA treatment on PCBPs by Western blotting and by
quantitative real-time (RT) PCR, and confirmed that our siRNA transfections
produced depletion of PCBP1 and PCBP2 in Huh7 cells (Fig. 4.1E).
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Figure 4.1. Accumulation of HIF1α in cells depleted of PCBPs. (A-D) Elevation of HIF1α
protein levels in cells lacking PCBP1 and PCBP2. PCBP1 and PCBP2 were depleted in
Huh7 cells using siRNA. After three days cells were treated with no DFO (A and B), 100 μM
DFO for 16h (A) or 2 h (C and D). Nuclear extracts were subjected to SDS-PAGE and
Western blotting using anti-HIF1α and anti-CREB as a loading control (A and C). HIF1α
levels were quantitated from three independent experiments and expressed as a
percentage of control-treated cells, +/- SEM (B and D). (E) Confirmation of PCBP1 and
PCBP2 depletion by siRNA. Cytoplasmic extracts from Huh7 cells treated with siRNA as in
A, above, were subjected to SDS-PAGE and Western blotting using anti-PCBP1 and antiPCBP2. Membranes were reprobed with mouse anti-actin as a loading control. Molecular
weight standards are in kDa.
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Although depletion of PCBP1 and 2 appeared complete by Western blot,
RT-PCR data suggested that depletion of PCBP2 was less complete than that of
PCBP1 (13.3% vs. 5.6% mRNA remaining) and that simultaneous transfection
with siRNAs for both PCBP1 and PCBP2 resulted in less efficient depletion of
both (9.6% vs. 5.6% remaining for PCBP1 and 16.3% vs. 13.3% for PCBP2). To
examine whether the elevated HIF1α levels in cells lacking PCBPs was due to
off-target effects of the siRNAs, we transfected Huh7 cells with alternative
siRNAs of different sequences directed against other regions of the PCBP
mRNAs and found that these siRNAs also led to increased HIF1α in cells treated
and untreated with DFO. These data indicated that the elevation of HIF1α in cells
depleted of PCBP1 was not due to off target effects of the siRNA.
The elevated levels of HIF1α detected in cells lacking PCBPs could be
due to either an increase in HIF1α gene expression or a decreased rate of HIF1α
protein degradation. We examined the levels of HIF1α mRNA in cells depleted of
PCBPs using RT-PCR (Fig. 4.2A). Changes in HIF1α mRNA levels in PCBPdepleted cells were small and not large enough to account for the observed
changes in protein levels. We next examined the half-life of HIF1α protein in
Huh7 cells depleted of PCBP1 and 2 versus control cells. Cells were treated with
DFO for 2 hr, cycloheximide was added to block new protein synthesis, then cells
were collected at intervals and nuclear extracts examined by Western blotting
(Fig. 4.2B). HIF1α protein levels were quantitated and the half-life was calculated
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Figure 4.2 Increase in HIF1α half-life and activity in cells lacking PCBPs. (A) Lack of
change in HIF1α mRNA levels in cells depleted of PCBPs. Huh7 cells were depleted of
PCBP1, PCBP2 or both, untreated or treated with DFO for 2 hrs, and HIF-1α mRNA levels
measured by RT-PCR. Data are presented as a percentage of actin mRNA. Samples were
analyzed in triplicate and the experiment was repeated three times. Error bars indicated
SEM. (B and C) Increase in HIF1α half-life in cells depleted of PCBPs. Huh7 cells were
depleted of both PCBP1 and 2, then treated with 25 µM DFO for 2 h. Cycloheximide was
added to the medium and the cells were lysed after 0, 15, 45, 90 and 180 min of treatment.
HIF1α and CREB were detected by Western blotting as in Figure1 (B). Blots were
quantitated, HIF1α levels were normalized to CREB, and plotted as a percentage of T=0
levels (C). (D) Increased HIF1α transcriptional activity after depletion of PCBP1. A HeLa
cell line containing a triple copy of the HRE upstream of a luciferase reporter gene was
depleted of PCBP1, PCBP2 or both using siRNA. After 3 days, cells were harvested, lysed,
and firefly luciferase activity was measured. The experiment was replicated three times,
error bars indicate SEM. * indicates p< 0.05.
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(Fig. 4.2C). Consistent with previous reports, HIF1α was rapidly degraded in
control cells (t1/2 = 8 min.), while HIF1α exhibited much greater stability in
cells.depleted of PCBP1 and 2 (t1/2 = 50 min.). These data indicated that the
accumulation of HIF1α in cells depleted of PCBP1 was due to impaired
degradation of the protein.
We tested whether the increase in HIF1α protein was associated with an
increase in HIF1α transcriptional activity. A HeLa cell line that contains a stably
integrated copy of the firefly luciferase coding sequence under the control of a
triple copy of the HRE exhibits luciferase activity in proportion to the activity of
the HIF transcription factors (124). This cell line was depleted of PCBP1, PCBP2,
or both PCBP1 and 2 and luciferase activity was measured (Fig. 4.2D). Cells
treated with PCBP1 siRNA exhibited a 5-fold increase in luciferase activity, while
cells treated with siRNAs for both PCBP1 and 2 exhibited a 1.6- fold increase in
activity when compared to control cells. These data indicated that cells lacking
PCBP1 exhibited both an increase in HIF1α levels and an increase in HIFdependent transcription.

4.4.2 Reduced hydroxylation of HIF1α in cells lacking PCBPs
VHL-mediated degradation of HIF1α is dependent on the hydroxylation of
proline residues 402 and 564 on the oxygen-dependent degradation domain of
HIF1α (114-115). Cells lacking PCBPs may exhibit impaired degradation of
HIF1α because of impaired hydroxylation of these proline residues. We
measured the hydroxylation of proline 564 in A549 cells lacking PCBPs by
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blocking proteasome-mediated degradation with the inhibitor MG132 and
detecting HIF1α using an antibody that specifically recognizes the hydroxylated
form of proline 564 in HIF1α (HIF1α -OH) (Fig. 4.3A). A549 cells were selected
because they expressed higher levels of PHD2 mRNA than Huh7 cells and
HIF1α-OH was readily detectable. Nuclear extracts were probed for HIF1α-OH,
total HIF1α, and the nuclear loading control, CREB. HIF1α-OH was readily
detected in cells treated with no or control siRNA, while cells depleted of PCBP1
exhibited dramatically reduced levels of HIF1α-OH (36% of Control) and cells
lacking PCBP2 or PCBP1 and 2 exhibited moderately reduced HIF1α-OH (66%
and 56% of control, respectively. The specificity of the antibody for HIF1α-OH
was demonstrated by the absence of signal in untreated cells (-MG132), which
also had no detectable HIF1α, and the absence of signal in cells treated for 16 hr
with DFO alone (+DFO), which had abundant HIF1α. The decrease in HIF1αOH in cells depleted of PCBP1 occurred despite an increase in the level of total
HIF1α, suggesting that depletion of PCBPs was associated with a loss of HIF1α
prolyl hydroxylation.
The activity of the HIF prolyl hydroxylases can be measured using an
assay that relies on the specific interaction of pVHL with a HIF1α-derived peptide
containing hydroxyproline 564, but not with a peptide containing an unmodified
proline (125-126). We used HEK 293T cell lysates containing PHD to hydroxylate
a HIF1α synthetic peptide corresponding to residues 556-574, which had been
bound to magnetic beads. VHL protein was incubated with the peptide, and the
amount of pVHL captured by the peptide was measured by Western blotting (Fig.
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3B). HEK 293T cells were selected because they expressed more PHD2 than
Huh7 cells and depletion of PCBPs was very efficient with two sequential

Figure 4.3 Impaired HIF-1α hydroxylation and VHL binding after depletion of PCBPs.(A)
Decrease in hydroxylated HIF1α after depletion of PCBPs. A549 cells were depleted of
PCBP1, PCBP2 or both, then treated with 100 μM MG132 for 6 h followed by 25 μM DFO for
2 h. Nuclear extracts were analyzed by Western blotting with anti-HIF1α-OH, anti-HIF1α,
and anti-CREB. Untreated cells (-MG132) and cells treated with DFO alone were used as
controls. (B) Decrease in pVHL binding to hydroxylated HIF1α after depletion of PCBPs.
HEK293T cells depleted of PCBP1, PCBP2 or both were harvested and lysates were added
to immobilized synthetic HIF1α peptide containing proline 564. Peptides were washed and
HA-pVHL was allowed to bind to the HIF1α peptide. Bound HA-pVHL was measured by
Western blotting using anti-HA. Hydroxylated synthetic HIF1α peptide (Peptide-OH) was
used as the positive control and DFO treated cells (+DFO) were used as a negative control.
Nuclear extracts of HEK293T cells depleted of PCBPs were also analyzed for HIF1α protein
and CREB by Western blotting. (C and D) Confirmation of PCBP depletion by siRNA.
Cytoplasmic extracts from A549 cells (C) treated with siRNA as in A, above, or HEK293T
cells (D) were subjected to SDS-PAGE and Western blotting using anti-PCBP1 and antiPCBP2 antibodies as in Figure 1. The membranes were reprobed for actin. HEK293T cells
were sequentially transfected with siRNAs to deplete PCBP1 and PCBP2.
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transfections of siRNAs. Cells were treated with siRNAS for PCBP1 and 2 and
control siRNA, then lysed and assayed for PHD activity by the pVHL capture
method. Cells transfected with no or control siRNA exhibited readily detectable
PHD activity, while cells lacking PCBP1 and PCBP2, individually or in
combination, exhibited much lower levels of activity (38-13% of Control). The
specificity of the hydroxylated peptide for pVHL capture was confirmed using a
hydroxylated synthetic peptide as a positive control (Peptide-OH) and lysate from
cells treated with DFO as a negative control (+DFO). Here, HEK 293T cells
lacking PCBP2 exhibited a loss of PHD activity that was similar to that of cells
lacking PCBP1. Consistent with this observation, the increase in the total amount
of HIF1α in HEK 293T cells lacking PCBP1 and/or PCBP2 was also similar (Fig.
4.3B). Both A549 cells and HEK 293T cells were efficiently depleted of PCBPs
using siRNA (Fig. 4.3C and D).

4.4.3 Reduced metallation of PHD2 in cells lacking PCBPs
The reduced hydroxylation of HIF1α in cells lacking PCBPs could be
explained by reduced levels of PHD mRNA or protein, or by reduced specific
activity of the enzyme. We measured mRNA levels of PHD2 by RT-PCR and
found small differences (less than 2-fold) between control cells and cells lacking
PCBPs in Huh7, A549, or HEK 293T cell lines (Fig. 4.4A). PHD2 protein levels
did not significantly change in Huh7 (Fig. 4.4B), HEK 293 (Fig. 4.4C) , and A549
(Fig. 4.5A) cells after depletion of PCBPs. These data suggested that depletion
of PCBPs reduced the specific activity of PHD2 rather than affecting protein
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Figure 4.4 Decrease in PHD2 metallation after depletion of PCBPs. (A) Lack of change in
PHD2 transcript levels after depletion of PCBPs. PCBP1, PCBP2 or both were depleted
from Huh7, A549 and HEK293T cells by siRNA. PHD2 mRNA levels were measured by RTPCR and expressed as a percentage of actin. Error bars indicate SEM. (B) Lack of change
in PHD2 protein levels after depletion of PCBPs. PCBP1, PCBP2 or both were depleted in
Huh7 cells. PHD2 was detected in whole cell lysates by Western blotting using anti-PHD2.
The blot was reprobed for actin. (C) Less iron in immunoprecipitated PHD2 after depletion
of PCBPs. PCBP1, PCBP2 or both were depleted from HEK293T cells as in A, then cells
were transiently transfected with pcDNA3-PHD2-FLAG to overexpress PHD2. Cells were labeled
with 55Fe for 16 hrs before harvesting, then PHD2 was detected by Western blotting or PHD2 with its
iron ligands was immunoprecipitated using anti-PHD2. Immune complexes were subjected
to scintillation counting and the retained 55Fe was expressed as a percentage of the 55Fe
from control lysates. The experiment was replicated four times. Error bars indicate SEM, *
indicates p<0.05.
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levels. The activity of PHD2 is dependent on the incorporation of iron into the
enzyme. Therefore, we measured the amount of iron bound to PHD2 from cells
labeled in vivo with [55Fe]. HEK 293T cells were depleted of PCBPs, then
transiently transfected to overexpress a FLAG-epitope-tagged version of PHD2,
and, finally, labeled with [55Fe] for 16 hr. Cells were lysed and PHD2 with its iron
ligands was recovered by immunoprecipitation. After washing, immune
complexes were subjected to scintillation counting (Fig. 4.4C). The amount of
iron bound to PHD2 was significantly reduced in cells lacking PCBP1, PCBP2, or
PCBP1 and 2, although the differences measured were not large. There was no
difference in the amount of PHD2 protein present in the labeled cell lysates,
however (Fig. 4.4C, top panel). These data suggested that the loss of PHD
activity in the cells lacking PCBPs was due to a failure to incorporate the Fe(II)
cofactor.

4.4.4 Restoration of PHD2 activity with iron or purified PCBP1
We employed a more robust and quantitative assay to further characterize the
loss of PHD activity in cells lacking PCBPs. Peptides corresponding to residues
556-574 of HIF1α were immobilized, then lysates from A549 cells depleted of
PCBPs were incubated with the peptides in the presence of 2-oxoglutarate and
ascorbate. The amount of hydroxylation of proline 564 was measured using an
antibody that specifically recognized hydroxyproline 564 in the HIF1α-derived
peptide. When the hydroxylase assay included a relatively low concentration of
Fe(II), robust PHD activity was detected in control lysates, and essentially no
activity was detected in lysates from cells treated overnight with DFO (Fig. 4.5A).

87

Figure 4.5 Requirement of PCBPs for iron-dependent PHD activity. (A) Decrease in PHD
activity after depletion of PCBPs. A549 cells were depleted of PCBP1 and PCBP2 by
siRNA. Cells were harvested, lysed, and assayed for PHD protein level (upper panels) and
activity in the presence of 10 μM Fe(II). (B) Increased PHD activity after addition of
exogenous iron in lysates depleted of PCBPs. PHD2 activity was measured as in A, above,
in assays containing the indicated concentrations of iron. (C) Restoration of PHD activity
upon addition of iron-loaded PCBP1 protein to PCBP1-depleted lysates. PHD activity
measured as in A. Purified recombinant PCBP1 and BSA were loaded with Fe(II) and added
to lysates prior to measurement of PHD activity. Unliganded Fe(II) was used as an
additional control and all assays contained 10 μM Fe as a final concentration. Activity was
expressed as luminescence units. Assays were performed in triplicate, experiments were
replicated four or more times. Error bars represent SEM.
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Lysates from cells depleted of PCBP1, PCBP2, and PCBP1 and 2 exhibited a
67-71% reduction in PHD2 activity, confirming that PCBPs were required for full
PHD activity in cells. Purified recombinant PHD2 that lacks the iron cofactor can
be activated in vitro with high concentrations of Fe(II). We therefore tested
whether PHD activity could be restored in lysates from cells depleted of PCBPs
by treating the lysates with Fe(II) in vitro. Lysates from control cells exhibited full
PHD activity when assayed with or without exogenous iron (Fig. 4.5B),
suggesting that the PHD from these cells was fully metallated. In contrast,
lysates from cells depleted of PCBP1 and PCBP1 and 2 exhibited virtually no
PHD activity in the absence of exogenous iron, but were restored to nearly full
activity upon addition of exogenous iron. These data suggested that the loss of
PHD activity could be fully explained by the absence of the Fe(II) cofactor from
the enzyme in the PCBP-depleted lysates. We next tested whether addition of
purified, iron-loaded PCBP1 could restore PHD activity. Purified recombinant
PCBP1 (P1) was incubated anaerobically with Fe(II) and added to lysates from
cells depleted of PCBPs. The lysates then assayed for PHD activity (Fig. 4.5C).
Iron-loaded bovine serum albumin (BSA) and unliganded Fe(II) were used as
controls, and the final concentration of iron (10 μM) was the same for all
samples. Purified, iron-loaded PCBP1 was able to restore PHD activity to near
control levels in lysates from cells lacking PCBP1 and to partially restore activity
in lysates from cells lacking PCBP1 and 2. In contrast, addition of iron-loaded
PCBP1 to lysates from cells lacking PCBP2 was no more effective than ironloaded albumin or iron alone in restoring PHD activity. These data indicated that
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iron-loaded PCBP1 could restore PHD activity in vitro, and they also suggested
that PCBP1 and PCBP2 have non-redundant functions and may cooperate in the
delivery of iron to PHD.

4.4.5 Direct in vivo interactions between PCBP1 and PHD2
PCBP1 directly binds to ferritin in the process of delivering iron for
mineralization, and, in yeast cells, this interaction is dependent on the presence
of the iron ligand (55). We examined the in vivo binding of PCBP1 to PHD2 in
HEK 293T cells by transiently overexpressing PHD2 and testing for the presence
of PHD2 in immune complexes precipitated using antibodies against PCBP1
(Fig. 4.6A). To test the effects of iron on interactions between PHD2 and PCBP1,
cells overexpressing PHD2 were treated overnight with iron or DFO prior to
harvesting. Co-immunoprecipitation of PHD2 with PCBP1 was readily detected in
control cells not treated with iron or DFO. No PCBP1 or PHD2 was detected in
immunoprecipitates using bulk IgY as a control antibody. Treatment of cells with
iron was associated with an increase in the amount of PHD2 bound to
precipitated PCBP1 when compared to untreated cells, and treatment of cells
with DFO was associated with a large decrease in the co-precipitated PHD2. No
significant differences in the amount of PHD2 were apparent in whole cell lysates
prior to immunoprecipitation. Because overexpression could favor nonspecific
protein-protein interactions, we also tested the binding of endogenous PCBP1 to
endogenous PHD2 in the absence of transient overexpression (Fig.4 6B). Again,
PHD2

was

readily

detected

in

immune

complexes

obtained

after

immunoprecipitation of PCBP1, but not in control IgY immunoprecipitations.

90
Here, the effects of iron manipulation were much less apparent. A measurable
increase in PHD2 binding to PCBP1 was occasionally, but not consistently,
detected in iron-treated cells when compared to untreated cells. Changes in the
amount of bound PHD2 were similarly small in DFO-treated cells. Iron

Figure 4.6. Direct interaction of PCBP1 with PHD2. (A) Iron-dependent coimmunoprecipitation of PHD2 with PCBP1 in cells overexpressing PHD2. HEK293T cells
were transiently transfected with pcDNA3-PHD2-FLAG followed by overnight addition of 20
μM ferric chloride or 100 μM DFO. PCBP1 was immunoprecipitated from 1.5 mg of whole
cell lysate using anti-PCBP1 coupled to beads, or bulk IgY coupled to beads as a negative
control. In panels on right, immune complexes were analyzed by Western blotting for
PHD2 and PCBP1. Panels on left were Western blots of whole cell lysates before
immunoprecipitation. (B) Co-immunoprecipitation of PHD2 with PCBP1 in cells expressing
endogenous levels of PHD2. HEK293T cells were treated with either 20 μM ferric chloride
or 100 μM DFO overnight and immunoprecipitations were carried out as in A, above, using
3 mg of whole cell lysate.
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manipulation had no effect on the total levels of PHD2 or PCBP1 in the whole cell
lysates. These data showed a direct physical interaction between PCBP1 and
PHD2, but whether iron levels affected this interaction appeared to differ
depending on the level of expression of PHD2.

4.4.6 Genetic and physical interactions of PCBP1 with FIH
FIH1 is an asparaginyl hydroxylase of the same Fe- and 2-OG-dependent
dioxygenase family as the PHDs and we questioned whether FIH1, similar to
PHD, also required PCBPs for Fe-dependent activation. FIH1 hydroxylates
Asn803 and Asn851 in the carboxyl-terminal transactivation domains (CADs) of
HIF1α and HIF2α, respectively (120-121). This modification does not lead to
degradation of the CADs, but instead prevents the association of transcriptional
co-activators with HIF, thereby blocking the activity of the HIFα CADs. Fusion of
the CADs to the Gal4 DNA-binding domain (GalDBD) permits the measurement
of FIH1 hydroxylase activity through the capacity of FIH1 to inhibit the
GalDBD/HIF2αCAD-dependent transcription of a Gal-responsive luciferase
reporter. HEK293 cells were depleted of PCBPs, then co-transfected with
plasmids expressing the GalDBD/HIF2αCAD, wild type FIH1, and a luciferase
reporter under the control of a Gal4-responsive promoter (5XGRE). Mutation of
Asn851 to Ala in HIF2α blocks hydroxylation of the Asn residue by FIH1,
resulting in constitutive activation of the HIF2α CAD. Therefore, a second
GalDBD/HIF2αCAD plasmid containing the N851A substitution was also
transfected. In cells treated with control siRNA, FIH was fully active, and
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Figure 4.7 Genetic and physical interactions of PCBP1 with FIH1. (A) Loss of FIH1 activity
in cells lacking PCBP1. HEK293 cells were depleted of PCBP1 and 2 with siRNA, then cotransfected with plasmids encoding the GalDBD/HIF2α CAD or the N851A mutant CAD,
Gal4-responsive luciferase reporter, control renilla luciferase, and FIH1. Normalized
luciferase activity was expressed as a fold-increase over the activity of control siRNA
treated cells. Data are the average of three transfections, error bars indicate SEM. (B)
Lysates from A were subjected to Western blotting for FIH1 and reprobed for actin. (C) Coimmunoprecipitation of FIH1 with PCBP1. HEK293T cells transiently overexpressing FIH1
were treated with iron and DFO, then PCBP1 was immunoprecipitated as in Fig. 6. Whole
cell lysates and immune complexes were blotted for FIH1 and PCBP1.
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luciferase activity was very low (Fig. 4.7A). In contrast, control cells expressing
the N851A CAD exhibited 10-fold higher luciferase activity. Cells depleted of
PCBP1 exhibited a 5-fold increase in luciferase activity when compared to
control, and cells depleted of PCBP1 and 2 exhibited a 3-fold increase in activity.
Similar to PHD2, depletion of PCBPs had no effect on FIH1 protein levels (Fig.
4.7B) and efficient depletion of PCBPs by siRNA was confirmed. These data
suggested that cells lacking PCBP1 had reduced FIH1 activity. We tested
whether FIH1 was bound to PCBP1 in cells by overexpressing FIH1 in HEK293
cells, immunoprecipitating endogenous PCBP1, and examining immune
complexes for co-precipitation of FIH1 (Fig. 4.7C). Similar to PHD2, FIH1 was
detectable in immune complexes containing PCBP1, but not in control IgY
immunoprecipitations. Unlike PHD2, only immune complexes from cells treated
with iron contained significant co-precipitated FIH1. These data suggest that
PCBP1 may also act as an iron chaperone for FIH1.

4.5

Discussion
Although most non-heme iron enzymes receive their metal cofactor

through an unknown mechanism, our studies indicated that PHDs, the prolyl
hydroxylases that modify HIF1α, require members of the PCBP family of iron
chaperones/RNA binding proteins to incorporate Fe(II) into their active sites.
Cells lacking PCBP1 exhibited reduced PHD activity, which resulted in less prolyl
hydroxylation of HIF1α, less degradation of HIF1α through the pVHL-proteasome
pathway, accumulation of HIF1α, and increased HIF1α transcriptional activity.
Because the loss of PHD activity was associated with a loss of the iron cofactor
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in vivo and in vitro, PCBP1 must be involved in the metallation of PHD.
Previously, we have shown that depletion of PCBP1 in Huh7 cells does not result
in a change in iron uptake activity; therefore, cellular iron for metallation of PHD
must be present. We found that iron-loaded PCBP1 specifically restored activity
to inactive PHD in vitro and that PCBP1 and PHD2 physically interacted in vivo
by co-immunoprecipitation. Thus, we propose that PCBP1 is an iron chaperone
for PHD as well as for ferritin. The loss of FIH1 activity in cells lacking PCBP1
and the binding of PCBP1 to FIH1 in vivo suggest that PCBP1 may act as an iron
chaperone for a second member of the Fe- and 2-OG-dependent oxygenases.
Treatment of cells with DFO produced a large decrease in the binding of PCBP1
to PHD2 when PHD2 was overexpressed, but not when PHD2 was expressed at
endogenous levels. An explanation for this result may be that the affinity of
PCBP1 for PHD2 is decreased in the absence of the iron ligand, but iron
chelation with DFO only leads to limiting amounts of the Fe-PCBP1 species
when PHD2 is present at high levels.
In these studies, depletion of PCBP2 had a variable effect on
hydroxylation and degradation of HIF1α. In Huh7 and A549 cells, the effect of
PCBP2 depletion on HIF1α prolyl hydroxylation and total protein accumulation
was small, while in HEK 293T cells, the effect of PCBP1 or PCBP2 depletion was
large, and similar for both. In contrast, direct measurement of PHD activity in
lysates from A549 cells indicated that depletion of PCBP2 resulted in a dramatic
decrease in activity, which was similar to that observed with depletion of PCBP1.
One possible explanation for these results is that our depletion of PCBP2 by
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siRNA was incomplete, and residual PCBP2 contained sufficient iron chaperone
activity to maintain activity in PHDs. This small amount of activity may be
sufficient to hydroxylate and destabilize a fraction of the HIF1α protein, but is too
small to measure as significantly greater than the PHD activity of cells lacking
PCBP1. Also, PCBP3 and 4 may also have iron chaperone activity and be
expressed at different levels in different cell types. We have previously shown
that expression of PCBP2 in yeast cells containing human ferritin activates the
iron deficiency response of yeast, indicating that PCBP2 can disrupt iron
homeostasis in yeast (55). Preliminary data indicate that PCBP2 can bind both
iron and ferritin, suggesting that PCBP2 can also function as an iron chaperone
(A.N., T.S., and C.C.P., unpublished observations).
Our data do not suggest, however, that PCBP1 and PCBP2 can
functionally substitute for each other. Cells lacking PCBP1 or 2 contain wild-type
levels of the other paralog. Furthermore, while addition of purified, iron-loaded
PCBP1 to lysates lacking PCBP1 fully restored PHD activity, addition of PCBP1
did not restore activity to lysates lacking PCBP2. PCBP1 and PCBP2 may
function as a heterooligomeric complex to deliver iron to targets such as ferritin
and PHD. PCBP1 and PCBP2 bind to each other when in complex with mRNA
(56) and we have confirmed this interaction (data not shown). Our data suggest a
model in which PCBP1, in complex with PCBP2 or another PCBP family
member, binds iron and interacts with target non-heme iron enzymes to donate
metal to the active site. The differences in HIF1α accumulation that occurred with
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depletion of PCBP1 versus PCBP2 may reflect the activity of PCBP1 in complex
with PCBP3 or PCBP4, which are generally expressed at lower levels in cells.
Our studies indicate that both ferritin and PHD receive iron from PCBPs.
These enzymes are structurally dissimilar, but have certain characteristics in
common that may point to mechanisms of iron donation. Both ferritin and PHD2
can fold into their native conformations in the absence of metals. Thus, PCBP1
could interact with these targets posttranslationally to donate iron. The H-chain of
ferritin catalyzes the oxidation of Fe(II) to Fe(III) for ferritin core mineralization,
and the ferroxidase center structurally and mechanistically resembles the
catalytic centers of the oxo-bridged diiron family of monooxygenases (106-107).
However, PCBP1 likely does not provide iron directly to the ferroxidase sites of
ferritin, as these sites are located on the interior surface of the ferritin sphere.
Iron ions are thought to gain access to the ferroxidase sites through pores
formed by the subunits arranged along the three-fold axes of symmetry. These
pores are lined with hydrophilic residues and PCBP1 could donate Fe(II) to the
His, Asp, and Glu residues that line the funnel-shaped channels. The active sites
of PHD2 and other enzymes of this class are solvent-exposed and coordinates a
single Fe(II) through a His-Xxx-Asp/Glu…His triad located deep in the active site
pocket (112-113). Thus, the iron ligands and the coordination environment in
these two enzymes are similar.
Given that PCBP1 serves as an iron chaperone for these two diverse
target enzymes, we suggest that it is highly likely that other enzymes of the
Fe(II)- and 2-OG oxygenase class will require PCBPs for metallation. Sequence
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analysis of the human genome indicates the presence of more than 60 enzymes
of these classes, many of which have not been functionally characterized, but are
predicted to oxidatively modify a broad range of substrates (112-113). Members
of the amino acid hydroxylase subclass of these enzymes catalyze the posttranslational modification of proteins by hydroxylating the amino acid side chains
of proline, lysine, asparagine, aspartate, and tryptophan. In addition to its role in
HIF regulation, FIH functions in mice as a regulator of metabolism, likely by
hydroxylating asparagine residues on proteins other than HIF (127). This class
also includes the collagen prolyl and lysyl hydroxylases, mutations in which
cause connective tissue diseases in humans. A subclass of the 2-OG oxygenase
family is defined by the presence of the jumonji C domain and members of this
sub-class catalyze the oxidative demethylation of mono-, di-, and tri-methylated
lysine residues located in histone proteins. The Jhdm2a histone demethylase
plays a role in fat and energy metabolism in mice (128). Another subclass of this
family resembles the AlkB demethylase of E. coli. Eight members of this subclass
have been identified in humans with activities that include the dealkylation and
oxidative demethylation of modified bases in both DNA and RNA. The activities
of these enzymes are predicted to have a major role in DNA repair and the
regulation of gene expression. Mutations in the fat-mass and obesity-associated
gene, FTO, a 2-OG-dependent enzyme of the AlkB subclass, are associated with
obesity in children and adults (129-132). Mice lacking FTO exhibit loss of adipose
tissue and increased energy expenditure (133). Perhaps it is a coincidence that,
despite having presumably differing activities and specificities, several of the 2-
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OG-dependent enzymes seem to function in the regulation of energy
metabolism. Alternatively, these enzymes may be poised to respond to changes
in cellular energy balance because they require 2-OG, a major product of the
TCA cycle, as a co-substrate.
Our studies have not addressed whether PCBP1 is involved in the delivery
of iron to the other major class of non-heme iron enzymes, the oxo-bridged diiron
family. Ferritin may be a special case, in that PCBP1 cannot interact directly with
the active site of the enzyme. Whether PCBPs can deliver iron to the active sites
of these enzymes remains to be determined. The mechanism by which PCBPs
acquire cytosolic iron is unknown. In yeast, cytosolic monothiol glutaredoxins are
required to make iron available to iron-requiring enzymes (59). Whether PCBPs
interact with these glutaredoxins awaits further study.
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CHAPTER 5
Summary and Future Directions
5.1

Prelude
Iron’s unique capacity to accept and donate electrons allows it to play a

very important role in almost all possible biological pathways including DNA
synthesis, oxygen transport, cell division, etc (2). While low levels of iron
accounts for iron deficiency diseases such as anemia, and it impairs cognitive
development of the newborns, high levels of iron are associated with disorders
like Friedrich’s Ataxia, Alzheimer’s disease, Parkinson’s Disease, etc (99). A
reaction between free iron and hydrogen peroxide leads to the formation of
reactive oxygen species (ROS) that destroys DNA and compromises cellular
efficacy (134). With no known mechanism for excretion, iron levels must be
properly regulated when it is in the body.
Various proteins are involved in maintaining cellular iron homeostasis.
Transferrin brings iron inside the cell (135), Ferritin stores iron (55), Frataxin
possibly serves as iron chaperone for iron-sulfur cluster assembly (136) and
there are numerous additional important proteins. These iron binding proteins
help to maintain cellular iron homeostasis by allowing the cell to make proper use
of iron while at the same time protecting the cell from toxic effects from the metal.
Recent breakthroughs regarding the cytosolic iron chaperone for Ferritin have
provided new insights in the understanding iron homeostasis at a much deeper
level than has previously been attained. Poly (rC) Binding Proteins recovered an
iron loading deficiency for Ferritin when both were expressed in yeast, confirming
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it plays a role in maintaining cellular iron homeostatsis. Using the tools and
techniques available in the lab, I have characterized PCBP2 and frataxin, and
studied their metal binding properties. The main conclusions of my work are
summarized below.

5.2

Summary
PCBP’s have been hypothesized to serve as iron chaperones. Following

optimization of conditions, PCBP2 was expressed with yield of 5-8mg/L yield and
95% purity in single step purification.

Approaches taken to characterize the

secondary structure revealed PCBP2 has a high helical content which is
consistent with the structure solved of a PCBP2 domain (57-58).

With the

melting temperature of 56 ± 2.5 °C, PCBP2 appears to be a stable protein.
Using ITC, I was able to show PCBP2 is a metal binding protein, which
binds iron at 2 sites with micromolar binding affinity. Furthermore, with the help of
ITC, I was able to study the interaction between apo/holo-PCBP2 and Ferritin.
Ferritin did not interact with PCBP2 in the absence of iron, but showed an
exothermic profile of heat release with holo-PCBP2, confirming PCBP and
Ferritin interact with each other only in the presence of iron.
With the use of XAS, the electronic environment of iron bound to PCBP2
was explored. It showed that iron bound to PCBP2 is stable as ferrous metal, and
it exists in a nearest ligand environment consisting of 6 coordinate O/N based
ligands. These data provide a structural picture of metal bound to PCBP1 that
serve as a basis for future studies of iron transfer with ferritin.
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5.3

Future Directions:
A long range goal of the lab is to characterize PCBP2 at the atomic,

molecular and cellular levels. The central hypothesis of my project was that the
PCBP family of proteins serve as iron chaperones for different tissue specific
Ferritins and in additional pathways that require iron. Understanding the role of
the PCBP’s at the atomic, molecular, and cellular levels will contribute to the
development of a broad understanding of iron storage and utilization events
essential for life. With 2 billion of people worldwide suffering from nutritional
disorders related to iron deficiency and large number of iron related disorders,
the study of iron homeostasis in every detail possible must be explored. The
binding affinity of iron to Ferritin, related to the storage and release of metal have
been very well documented; whereas, there has been less done to explore how
the protein acquires metal from the cytosol. The new finding that PCBP serves as
an iron chaperone has given new insights to the understanding of iron
homeostasis.
Given that PCBP’s bind iron, identification of active sites residues for
metal binding via site directed mutagenesis will further help to decipher the role
of PCBP’s in iron homeostasis. Specifically, by targeting conserved Asp and
Glu’s in the protein through mutagenesis, we may be able to elucidate how the
protein functions during the iron binding and delivery.
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Iron is a micronutrient that acts as a cofactor in many prosthetic groups
involving itself in almost every biological process. Iron is the key component in
our body fluid, flowing in our veins all the time. Iron deficiency disorders affects
more than 9 million people worldwide. Similarly, a high level of iron is associated
with various disorders which suggest that in order for body to function properly
level of iron should be tightly regulated. Many iron binding proteins help in
maintaining cellular iron homeostasis by keeping iron in reduced form.
Working on the hypothesis that Poly (rC) Binding Protein family serve as
iron chaperone, research presented here shows that PCBP2 binds ferrous iron
with micromolar binding affinity. The structural data on PCBP2 shows that thus
bound iron is in 6-coordinate O/N ligand environment. Data presented here
characterizes PCBP2 as a dimeric protein, with high helical content.
Characterization of PCBP2 will serve as a base for exploring the roles of PCBP2
in cellular iron homeostasis.
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